Un diagnóstico de cáncer de pulmón llegó de repente para Emma Pompeo. Pero afortunadamente, ella tenía dos cosas a su favor: apoyo de su familia cuando aprendió de su diagnóstico y encontró a un doctor en un centro de cáncer comprensivo que podía contestar sus preguntas en español para que ella y su familia pudieran entender toda la nueva información. Su doctor le explicó bien sobre los biomarcadores de cáncer de pulmón, organizó los exámenes requeridos, y dio buenas recomendaciones de otros doctores quienes ayudaron a formar su equipo de salud. Estos diálogos eran increíblemente importantes mientras ella aprendía el nuevo vocabulario que es parte del diagnóstico de cáncer de pulmón y del tratamiento apropiado. INVITADOS Dr. Christian Rolfo es un Oncólogo Torácico y experto en oncología molecular, biopsias líquidas y desarrollo de nuevos fármacos en el ámbito de cáncer de pulmón y mesotelioma en el centro de Oncología Torácica de Mount Sinai. Emma Pompeo está viviendo con EGFR cáncer de pulmón. Ella dedica tiempo a ser una luchadora para pacientes, apoyando a otros en su experiencia con cáncer de pulmón. Notas del Programa | Transcripción

Un <a href="https://lcfamerica-org.translate.goog/lung-cancer-info/diagnosis/?_x_tr_sl=auto&amp;_x_tr_tl=es&amp;_x_tr_hl=en&amp;_x_tr_pto=wapp" rel="nofollow" target="_blank">diagnóstico de cáncer de pulmón</a> llegó de repente para Emma Pompeo. Pero afortunadamente, ella tenía dos cosas a su favor: apoyo de su familia cuando aprendió de su diagnóstico y encontró a un doctor en un centro de cáncer comprensivo que podía contestar sus preguntas en español para que ella y su familia pudieran entender toda la nueva información. Su doctor le explicó bien sobre <a href="https://lcfamerica.org/lung-cancer-info/diagnosis/biomarker-testing/" rel="nofollow" target="_blank">los biomarcadores de cáncer de pulmón</a>, organizó los exámenes requeridos, y dio buenas recomendaciones de otros doctores quienes ayudaron a formar su equipo de salud. Estos diálogos eran increíblemente importantes mientras ella aprendía el nuevo vocabulario que es parte del diagnóstico de cáncer de pulmón y del tratamiento apropiado. INVITADOS Dr. Christian Rolfo es un Oncólogo Torácico y experto en oncología molecular, biopsias líquidas y desarrollo de nuevos fármacos en el ámbito de cáncer de pulmón y mesotelioma en el centro de Oncología Torácica de Mount Sinai. Emma Pompeo está viviendo con EGFR cáncer de pulmón. Ella dedica tiempo a ser una luchadora para pacientes, apoyando a otros en su experiencia con cáncer de pulmón. <a href="https://lcfamerica.org/wp-content/uploads/2022/07/Ep-22-3-Notas-del-Programa-.pdf" rel="nofollow" target="_blank">Notas del Programa</a> | <a href="https://lcfamerica.org/wp-content/uploads/2022/07/LCFA-EP-22-3-Transcripcio%CC%81n.pdf" rel="nofollow" target="_blank">Transcripción</a>

Comprender los biomarcadores del cáncer de pulmón

For years, researchers knew different factors were causing lung cancer tumors to grow, but they didn't know why, or how to interrupt the process. Then, a group of lung cancer researchers discovered the EGFR biomarker, which opened the door for targeted therapies that were easier to take, more effective, and led to better patient outcomes than anything used before. Take this opportunity to hear from someone who had a part in discovering the first lung cancer biomarker. Learn more about the EGFR biomarker from Dr. Carbone – important information that every EGFR patient needs to know. Guest Dr. David Carbone is a lung cancer clinician, researcher and specialist at The Ohio State University Comprehensive Cancer Center. He’s been working on developing treatments for lung cancer for years, and played an important role in discovering the first targeted therapy aimed at the EGFR biomarker. Transcript | Video Podcast

For years, researchers knew different factors were causing lung cancer tumors to grow, but they didn't know why, or how to interrupt the process. Then, a group of lung cancer researchers discovered <a href="https://lcfamerica.org/lung-cancer-info/types-lung-cancer/egfr-positive-lung-cancer/" rel="nofollow" target="_blank">the EGFR biomarker</a>, which opened the door for targeted therapies that were easier to take, more effective, and led to better patient outcomes than anything used before. Take this opportunity to hear from someone who had a part in discovering the first lung cancer biomarker. Learn more about the EGFR biomarker from Dr. Carbone – important information that every EGFR patient needs to know. Guest <a href="https://lcfamerica.org/about/advisory/board/dr-david-carbone-m-d-ph-d/" rel="nofollow" target="_blank">Dr. David Carbone</a> is a lung cancer clinician, researcher and specialist at <a href="https://cancer.osu.edu/" rel="nofollow" target="_blank">The Ohio State University Comprehensive Cancer Center</a>. He’s been working on developing treatments for lung cancer for years, and played an important role in discovering the first targeted therapy aimed at the EGFR biomarker. <a href="https://lcfamerica.org/wp-content/uploads/2022/03/What-Every-EGFR-Patient-Needs-to-Know.pdf" rel="nofollow" target="_blank">Transcript</a> | <a href="https://youtu.be/M4kIBpqWRC0" rel="nofollow" target="_blank">Video Podcast</a>

What every EGFR patient needs to know

A lung cancer diagnosis can be very overwhelming. How do you make a connection and create a sense of community with people who truly understand what you’re going through?  Hear from two people living with EGFR lung cancer who are creating connections among others with the same biomarker. Learn how sharing experiences, information, and understanding, is creating hope with answers for those in the EGFR biomarker community - while advocating for more lung cancer research.Guests:Jill Feldman, lung cancer patient/advocate, follow her on Twitter @jillfeldman4 Ivy Elkins, lung cancer patient/advocate, follow her on Twitter @Ivybelkins Podcast Transcript Meet patient advocates Jill Feldman and Ivy Elkins. They are working hard to level the playing field for people living with EGFR lung cancer by: making sure that everyone has access to the best treatments and information building a network of support for people living with the same type of lung cancer they have.Resources:What do I need to know about biomarker testing? Targeted therapies for lung cancer treatment EGFR Resisters, a patient-driven community dedicated to improving the outcomes for those with EGFR positive lung cancer.

A lung cancer diagnosis can be very overwhelming. How do you make a connection and create a sense of community with people who truly understand what you’re going through?  Hear from two people living with EGFR lung cancer who are creating connections among others with the same biomarker. Learn how sharing experiences, information, and understanding, is creating hope with answers for those in the <a href="https://lcfamerica.org/lung-cancer-info/types-lung-cancer/egfr-positive-lung-cancer/" rel="nofollow" target="_blank">EGFR biomarker</a> community - while advocating for more lung cancer research.Guests: <a href="https://lcfamerica.org/lung-cancer-info/survivors/ovecoming-history-lung-cancer/" rel="nofollow" target="_blank">Jill Feldman</a>, lung cancer patient/advocate, follow her on Twitter <a href="https://twitter.com/jillfeldman4" rel="nofollow" target="_blank">@jillfeldman4</a> <a href="https://lcfamerica.org/lung-cancer-info/survivors/advocating-lung-cancer-research/" rel="nofollow" target="_blank">Ivy Elkins</a>, lung cancer patient/advocate, follow her on Twitter <a href="https://twitter.com/ivybelkins" rel="nofollow" target="_blank">@Ivybelkins</a> <a href="https://lcfamerica.org/wp-content/uploads/2022/02/LCFA-HWA-EP-22-1-EGFR-Biomarker-Buddies-Transcript.pdf" rel="nofollow" target="_blank">Podcast Transcript</a> Meet patient advocates Jill Feldman and Ivy Elkins. They are working hard to level the playing field for people living with EGFR lung cancer by: <ul><li>making sure that everyone has access to the best treatments and information</li> <li>building a network of support for people living with the same type of lung cancer they have.</li></ul>Resources: <ul><li><a href="https://lcfamerica.org/lung-cancer-info/diagnosis/biomarker-testing/" rel="nofollow" target="_blank">What do I need to know about biomarker testing</a>?</li> <li><a href="https://lcfamerica.org/lung-cancer-info/treatment/targeted-therapies/" rel="nofollow" target="_blank">Targeted therapies for lung cancer treatment</a></li> <li><a href="https://egfrcancer.org/" rel="nofollow" target="_blank">EGFR Resisters,</a> a patient-driven community dedicated to improving the outcomes for those with EGFR positive lung cancer.</li></ul>

EGFR Biomarker Community: Hope Living With Lung Cancer

Lung cancer is a disease that affects people: family, friends, co-workers, neighbors. It's a disease that comes with in some stark figures about survival and research funding. But the numbers don't lie, and they also show the amazing strides being made against the disease: increasing survival rates, incredible strides in treatment options, and ever-growing ranks of researchers dedicating their professional careers to improving the odds for people living with lung cancer. Join us for this episode of Hope With Answers: Living With Lung Cancer, where we talk about hope, by the numbers. Guests: Kim Norris, Lung Cancer Foundation of America co-founder and president Dr. Jessica Donington, professor of surgery at the University of Chicago Pritzker School of Medicine Dr. Triparna Sen, an assistant attending at Memorial Sloan Kettering Cancer Center Kellie Smith, PhD, assistant professor of oncology at Johns Hopkins Medicine   Show Notes | TranscriptBY THE NUMBERS: 20  The quickening pace of research the last 20 yearsTwenty years ago, the lung cancer treatments available were surgery, chemotherapy, and radiation. Then came the discovery of treatable lung cancer biomarkers. The discovery that each lung cancer tumor is unique opened up a whole new world of discovery. After that, immunotherapy opened up even more ways to treat different types of lung cancer. And for many people, living with lung cancer it has become more like managing a chronic disease rather than the usually fatal diagnosis it was just a handful of years ago.“... the entire landscape has changed for people diagnosed with lung cancer. I even wonder if my husband, who died 20 years ago, would still be alive if he had been able to take advantage of all the research that’s been happening in just the past five or ten years. We now know people living 8, 13, 15, and 19 years after diagnosis. And then we realized that these numbers are really powerful-- they’re not just black and white numbers, they’re people.“ - Kim NorrisBY THE NUMBERS: Double DutyLCFA Young Investigator Research Grants do double duty in the field of lung cancer research. Funding from foundations like the Lung Cancer Foundation of America is essential in building a pool of investigators. It takes a long time and a lot of money to go from a great idea and a bright star with a great mind to an NIH-funded investigator. But as Dr. Triparna Sen points out, these grants also help to train young investigators.“Like with this funding, we get postdocs and trainees and technicians into the lab. So we are essentially training the next generation of cancer investigators who will go on to become in independent investigators themselves. So you're not only just providing resource to advanced research, but you're also providing resource to train the next generation of cancer investigators. And I think that has a much more long term impact the next clinical trial. So I think overall, uh, the funding that I got from LCFA has been absolutely critical in developing me as a researcher. So thank you so much.”BY THE NUMBERS: 17LCFA has invested in 17 grants so far, and 10 of them have gone to women.Women in science face many challenges. When Dr. Donington got into lung cancer 15 years ago, it was a very male-dominated field in terms of the doctors who treated it and the researchers who performed the research. And I always believe that a group of physicians and researchers that matches their patients provides the best care.The Power Of The Patient Advocate VoiceWomen advocates are making a difference in lung cancer research as well. As Dr. Donington discusses, “Lung cancer for a long time has had a stigma issue as being seen as a male disease, with people who have smoked for 100 years. And it's just not, it's not that disease. And I think that our advocates which are very heavily female like a lot of cancer advocates are, have really done so much to change the face of lung cancer…. I think they do more to change lung cancer than even us as investigators.” Dr. Sen thinks that what the patient advocates do is they help bring system-wide issues to light that are required for clinical trial design for what is important for the actual patients who is the ultimate goal role for our researchers. And her goal is to work with patient advocates to make her scientific studies more relevant to the field, more timely, because she now understand by speaking to them the urgency of the situation, and so make it more timely.“And I think patient advocates play a very important role to help researchers learn like myself move discoveries towards clinical use, but do that in a more sort of not only timely fashion, but also help us design studies that are more relevant to clinical use.” - Dr. Triparna SenIn addition, patient advocates play an important role in bringing these disparities to light. Then these issues can be addressed by researchers and by clinicians and move them to incorporating equity in clinical trial.“I think so they play a very important role at multiple levels and LCFA has done an incredible job in connecting researchers to patient advocates.” - Dr. Triparna SenThe Pace of Research: Bench to Bedside“And I didn't think it was possible in my lifetime, but I suddenly think that, oh my gosh, we can double survival. We can get survival up to 25 and 30%. I feel like in a very short time, uh, with screening and the advancements in our current medications, it's just so possible. It's exciting.” - Dr. Jessica DoningtonThe time it takes for research to go from bench to bedside is getting faster all time. That’s the timeline: how long it takes for a discovery in the lab to make it to a patient who needs it. So, for example, when you're in a laboratory you hear about using mice and discoveries, but that's just in theory, then you have to bring it to the human and that takes time.“Bench to bedside has never been as fast as it is now in lung cancer. It is incredible. Things we never considered as little as five years ago are just commonplace now. It was very funny I was working with one of my colleagues and she said, "Oh, yeah, I don't treat one person the same way I did five years ago as a medical oncologist." And then I sat down and go, "Oh, you know what? I don't either." Like none of us do. So there's this whole synergy about the science too, as it advances in one area, it becomes easier to integrate it into others and it's really exciting.” - Dr. Jessica DoningtonResearch breakthroughs discovered five, six years ago are already in clinical trials.  So this bench to bedside medicine is a phenomenal thing to be a part of within the context of lung cancer.“As a PhD scientist, we very rarely see the fruits of our labor actually pan out in the clinic. I mean, it's very rare. But with lung cancer research, because it's moving at such a rapid pace, we are able to see these discoveries making their way into the clinic in an accelerated timeframe.” - Dr. Kellie SmithResearch = HopeThe goal of LCFA’s Young Investigator grant program is to attract the best and brightest minds into lung cancer research early in their careers. This LCFA grant is big enough that they can set up their labs and gather that first big collection of data.Then, they can use this data to apply for even larger grants that may one day lead to clinical trials and hopefully new treatments.BY THE NUMBERS: Investment in Grants $200,000 &gt;&gt; $4 MillionKellie Smith is a shining example of LCFA’s mission. Using her LCFA grants, she was generated preliminary data, made these really impactful discoveries, and then to applied for additional funding.“And, just based on my own personal experience, the LCFA Young Investigator award was the very first grant that I was ever awarded. I've been able to leverage that now into several million dollars worth of funding.”

Lung cancer is a disease that affects people: family, friends, co-workers, neighbors. It's a disease that comes with in some stark figures about survival and research funding. But the numbers don't lie, and they also show the amazing strides being made against the disease: increasing survival rates, incredible strides in treatment options, and ever-growing ranks of researchers dedicating their professional careers to improving the odds for people living with lung cancer. Join us for this episode of Hope With Answers: Living With Lung Cancer, where we talk about hope, by the numbers. Guests: <a href="https://lcfamerica.org/about/board/director/kim-norris/" rel="nofollow" target="_blank">Kim Norris</a>, Lung Cancer Foundation of America co-founder and president <a href="https://lcfamerica.org/about/advisory/board/dr-jessica-donington/" rel="nofollow" target="_blank">Dr. Jessica Donington</a>, professor of surgery at the <a href="https://pritzker.uchicago.edu/" rel="nofollow" target="_blank">University of Chicago Pritzker School of Medicine</a> <a href="https://lcfamerica.org/research-grants/improving-small-cell-lung-cancer-life-expectancy/" rel="nofollow" target="_blank">Dr. Triparna Sen</a>, an assistant attending at <a href="https://www.mskcc.org/cancer-care/types/lung/experts" rel="nofollow" target="_blank">Memorial Sloan Kettering Cancer Center</a> <a href="https://lcfamerica.org/research-grants/grants/awarded/dr-kellie-smith-2/" rel="nofollow" target="_blank">Kellie Smith, PhD</a>, assistant professor of oncology at <a href="https://www.hopkinsmedicine.org/profiles/details/kellie-smith" rel="nofollow" target="_blank">Johns Hopkins Medicine</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/12/HWA-Ep-21-12-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/12/LCFA-HWA-EP-21-12-transcript.pdf" rel="nofollow" target="_blank">Transcript</a>BY THE NUMBERS: 20  The quickening pace of research the last 20 years Twenty years ago, the lung cancer treatments available were surgery, chemotherapy, and radiation. Then came the discovery of treatable lung cancer biomarkers. The discovery that each lung cancer tumor is unique opened up a whole new world of discovery. After that, immunotherapy opened up even more ways to treat different types of lung cancer. And for many people, living with lung cancer it has become more like managing a chronic disease rather than the usually fatal diagnosis it was just a handful of years ago.“... the entire landscape has changed for people diagnosed with lung cancer. I even wonder if my husband, who died 20 years ago, would still be alive if he had been able to take advantage of all the research that’s been happening in just the past five or ten years. We now know people living 8, 13, 15, and 19 years after diagnosis. And then we realized that these numbers are really powerful-- they’re not just black and white numbers, they’re people.“ - Kim Norris BY THE NUMBERS: Double Duty LCFA Young Investigator Research Grants do double duty in the field of lung cancer research. Funding from foundations like the Lung Cancer Foundation of America is essential in building a pool of investigators. It takes a long time and a lot of money to go from a great idea and a bright star with a great mind to an NIH-funded investigator. But as Dr. Triparna Sen points out, these grants also help to train young investigators.“Like with this funding, we get postdocs and trainees and technicians into the lab. So we are essentially training the next generation of cancer investigators who will go on to become in independent investigators themselves. So you're not only just providing resource to advanced research, but you're also providing resource to train the next generation of cancer investigators. And I think that has a much more long term impact the next clinical trial. So I think overall, uh, the funding that I got from LCFA has been absolutely critical in developing me as a researcher. So thank you so much.” BY THE NUMBERS: 17 LCFA has invested in 17 grants so far, and 10 of them have gone to women. Women in science face many challenges. When Dr. Donington got into lung cancer 15 years ago, it was a very male-dominated field in terms of the doctors who treated it and the researchers who performed the research. And I always believe that a group of physicians and researchers that matches their patients provides the best care.The Power Of The Patient Advocate Voice Women advocates are making a difference in lung cancer research as well. As Dr. Donington discusses, “Lung cancer for a long time has had a stigma issue as being seen as a male disease, with people who have smoked for 100 years. And it's just not, it's not that disease. And I think that our advocates which are very heavily female like a lot of cancer advocates are, have really done so much to change the face of lung cancer…. I think they do more to change lung cancer than even us as investigators.” Dr. Sen thinks that what the patient advocates do is they help bring system-wide issues to light that are required for clinical trial design for what is important for the actual patients who is the ultimate goal role for our researchers. And her goal is to work with patient advocates to make her scientific studies more relevant to the field, more timely, because she now understand by speaking to them the urgency of the situation, and so make it more timely.“And I think patient advocates play a very important role to help researchers learn like myself move discoveries towards clinical use, but do that in a more sort of not only timely fashion, but also help us design studies that are more relevant to clinical use.” - Dr. Triparna Sen In addition, patient advocates play an important role in bringing these disparities to light. Then these issues can be addressed by researchers and by clinicians and move them to incorporating equity in clinical trial.“I think so they play a very important role at multiple levels and LCFA has done an incredible job in connecting researchers to patient advocates.” - Dr. Triparna Sen The Pace of Research: Bench to Bedside “And I didn't think it was possible in my lifetime, but I suddenly think that, oh my gosh, we can double survival. We can get survival up to 25 and 30%. I feel like in a very short time, uh, with screening and the advancements in our current medications, it's just so possible. It's exciting.” - Dr. Jessica Donington The time it takes for research to go from bench to bedside is getting faster all time. That’s the timeline: how long it takes for a discovery in the lab to make it to a patient who needs it. So, for example, when you're in a laboratory you hear about using mice and discoveries, but that's just in theory, then you have to bring it to the human and that takes time.“Bench to bedside has never been as fast as it is now in lung cancer. It is incredible. Things we never considered as little as five years ago are just commonplace now. It was very funny I was working with one of my colleagues and she said, "Oh, yeah, I don't treat one person the same way I did five years ago as a medical oncologist." And then I sat down and go, "Oh, you know what? I don't either." Like none of us do. So there's this whole synergy about the science too, as it advances in one area, it becomes easier to integrate it into others and it's really exciting.” - Dr. Jessica Donington Research breakthroughs discovered five, six years ago are already in clinical trials.  So this bench to bedside medicine is a phenomenal thing to be a part of within the context of lung cancer.“As a PhD scientist, we very rarely see the fruits of our labor actually pan out in the clinic. I mean, it's very rare. But with lung cancer research, because it's moving at such a rapid pace, we are able to see these discoveries making their way into the clinic in an accelerated timeframe.” - Dr. Kellie Smith Research = Hope The goal of LCFA’s Young Investigator grant program is to attract the best and brightest minds into lung cancer research early in their careers. This LCFA grant is big enough that they can set up their labs and gather that first big collection of data.Then, they can use this data to apply for even larger grants that may one day lead to clinical trials and hopefully new treatments.BY THE NUMBERS: Investment in Grants $200,000 &gt;&gt; $4 Million Kellie Smith is a shining example of LCFA’s mission. Using her LCFA grants, she was generated preliminary data, made these really impactful discoveries, and then to applied for additional funding.“And, just based on my own personal experience, the LCFA Young Investigator award was the very first grant that I was ever awarded. I've been able to leverage that now into several million dollars worth of funding.”

Investment in grants change the future for lung cancer patients

Our guests talk about how peers, friend-tors, and academic mentors can help you see potential in yourself that you may not have known. All this support is especially important to the success of minority and ethnic researchers who are looking to focus on a lung cancer specialty.“Mentors are those guiding lights that help us to progress to the next stage and to see paths where we may not have seen them before.” - Dr. Jarushka NaidooGuestsDr. Jarushka Naidoo, a consultant medical oncologist at Beaumont Hospital in Dublin, Ireland who focuses on immunotherapy and is an LCFA Young Investigator Grant recipient Dr. David Tom Cooke, a cardiothoracic surgeon at the University of California Davis Health System specializing in cancer surgery Dr. Christian Rolfo, a thoracic oncologist who is associate director for clinical research in the Center for Thoracic Oncology/Tisch Cancer Institute, Mount Sinai, New York. Show Notes | TranscriptionAcademic Mentors Help Make the ConnectionsAcademic mentors are necessary for advancing a researcher’s career and accessing lung cancer research funding. There are a variety of approaches to mentoring and different mentors may bring different skills. A mentor can mean different things at different stages in your career. A mentor fundamentally means a teacher. Like teachers, a researcher needs a different type of teaching at different times in their careers. One of the things that is important about mentors is to realize that not all mentors are going to teach a researcher the same lessons, but the mentee will carry those lessons through their career. Some of the different kinds of mentors are: peer mentors – at your stage or a little bit senior to you who might teach you how to get things done friendtors – people who are at your stage and understand what you might need day-to-day. classic academic mentors – a senior mentor who has a bird’s eye view of careers and how they can guide your career forwardThe Importance of Finding Academic Mentors“...it's important to establish a mentor, someone who introduces you to the scientific method from an early age, and guides you through a proper development pathway to understanding investigated research.” - Dr. David Tom Cooke You can take skills from mentors from different areas covering your needs, and giving you expertise in different fields. A good academic mentor can instill a genuine love for the specialty. They can help to navigate the interplay between understanding the different specialties that contribute to the world of oncology, and the true commitment to lifelong learning.How Lung Cancer Research Can Benefit From An Increase In Investigators From Minority And Ethnic CommunitiesResearchers who bring a culturally sensitive perspective to lung cancer, can make a huge difference in research and in the communities they represent. As an underrepresented medicine physician, Dr. Cook understands in a culturally competent way, the mistrust of the healthcare system from the black and African American community. He can just sit down and talk with patients with that understanding. He can help to allay their fear of a clinical trial. In addition, Dr. Cook can help the healthcare institution understand how best to support these patients to promote them enrolling into clinical trials. Currently there is even more attention on the ability of a clinical study to attract and enroll under- engaged communities for a given research question. The grant applications are evaluated on how this research will reach out to underserved communities or underserved populations. Such as will women be enrolled in this trial? So, that is key to addressing questions about disparate populations and equal opportunities for participation. Thus a grant application will be evaluated based on these rules.Academic Mentors Help Navigate The Equity Space For Young PhysiciansOf course, many aspiring doctors do not attend the top rated University Medical School Programs, many of which are Ivy League schools. Many of the students who attend medical school programs at smaller schools may face unique challenges in their attempts to specialize in lung cancer research. And, the challenges are even greater for students from underrepresented minority groups. However, there is a misperception that investigative science and research only occurs at the Ivy League level. That misperception is not amongst researchers throughout this country and others, but mainly in the lay population. Looking at all National Cancer Institute Comprehensive Designated Cancer Centers, there are over 40 research universities. The majority of these facilities do not reside within the Ivy League environment. Look at the hundreds and hundreds of millions of dollars of research funds that goes into funding research, both in the public and private sector. The vast majority goes into other institutions, that include UC Davis Health and Johns Hopkins Medical Center. The key here is, if you are an individual, especially a person from an underrepresented medicine background, it's important to establish an academic mentor. Especially important, finding someone who introduces you to the scientific method from an early age. Then guides you through a proper development pathway to understanding investigated research.Academic Mentors and Research FundingThere are also underutilized funding resources. Typically, resources may be underutilized because many people aren't aware of them. ​​Dr. Christian Rolfo stresses that it’s very important that mentees to be very proactive. “Because if you are sitting there, even if you are coming from a big institution you are sitting there and you don't take the opportunities, nobody will knock your door.” Dr. Cooke believes the key is cross demographic mentorship. An academic mentor doesn't have to look like you or come from the same background, or even quite frankly be in the same political persuasion. But they have to have faith in your abilities, and their only goal in mentoring you, is seeing your success. For example Dr. Cooke cited one of his earliest academic mentors, Dr. Marion Katchlin. “She was older, I was younger, she was wealthy, I was not. She was a smoker, I wasn't. But we both loved immunology. And she took a specific interest in my career, and she taught me that I shouldn't limit myself in any way, and I should strive for the best in any opportunity I want to strive for.” Resources How an LCFA/IASLC Grant Benefits Lung Cancer Research LCFA Research Grants How to find funding for lung cancer research

Our guests talk about how peers, friend-tors, and academic mentors can help you see potential in yourself that you may not have known. All this support is especially important to the success of minority and ethnic researchers who are looking to focus on a lung cancer specialty.“Mentors are those guiding lights that help us to progress to the next stage and to see paths where we may not have seen them before.” - Dr. Jarushka Naidoo Guests <a href="https://lcfamerica.org/research-grants/precision-medicine-and-lung-cancer/" rel="nofollow" target="_blank">Dr. Jarushka Naidoo</a>, a consultant medical oncologist at Beaumont Hospital in Dublin, Ireland who focuses on immunotherapy and is an LCFA Young Investigator Grant recipient <a href="https://health.ucdavis.edu/team/surgicalservices/1144/david-cooke---cancer---surgery---cardiothoracic---surgery---thoracic---surgery---robotic---robotic-surgery-sacramento" rel="nofollow" target="_blank">Dr. David Tom Cooke</a>, a cardiothoracic surgeon at the University of California Davis Health System specializing in cancer surgery <a href="https://www.mountsinai.org/profiles/christian-rolfo" rel="nofollow" target="_blank">Dr. Christian Rolfo</a>, a thoracic oncologist who is associate director for clinical research in the Center for Thoracic Oncology/Tisch Cancer Institute, Mount Sinai, New York. <a href="https://lcfamerica.org/wp-content/uploads/2021/11/HWA-EP-21-9-Academic-Mentors-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/11/LCFA-HWA-EP-21-9-Transcript.pdf" rel="nofollow" target="_blank">Transcription</a>Academic Mentors Help Make the Connections Academic mentors are necessary for advancing a researcher’s career and accessing lung cancer research funding. There are a variety of approaches to mentoring and different mentors may bring different skills. A mentor can mean different things at different stages in your career. A mentor fundamentally means a teacher. Like teachers, a researcher needs a different type of teaching at different times in their careers. One of the things that is important about mentors is to realize that not all mentors are going to teach a researcher the same lessons, but the mentee will carry those lessons through their career. Some of the different kinds of mentors are: <ul><li>peer mentors – at your stage or a little bit senior to you who might teach you how to get things done</li> <li>friendtors – people who are at your stage and understand what you might need day-to-day.</li> <li>classic academic mentors – a senior mentor who has a bird’s eye view of careers and how they can guide your career forward</li></ul>The Importance of Finding Academic Mentors “...it's important to establish a mentor, someone who introduces you to the scientific method from an early age, and guides you through a proper development pathway to understanding investigated research.” - Dr. David Tom Cooke You can take skills from mentors from different areas covering your needs, and giving you expertise in different fields. A good academic mentor can instill a genuine love for the specialty. They can help to navigate the interplay between understanding the different specialties that contribute to the world of oncology, and the true commitment to lifelong learning.How Lung Cancer Research Can Benefit From An Increase In Investigators From Minority And Ethnic Communities Researchers who bring a culturally sensitive perspective to lung cancer, can make a huge difference in research and in the communities they represent. As an underrepresented medicine physician, Dr. Cook understands in a culturally competent way, the mistrust of the healthcare system from the black and African American community. He can just sit down and talk with patients with that understanding. He can help to allay their fear of a clinical trial. In addition, Dr. Cook can help the healthcare institution understand how best to support these patients to promote them enrolling into clinical trials. Currently there is even more attention on the ability of a clinical study to attract and enroll under- engaged communities for a given research question. The grant applications are evaluated on how this research will reach out to underserved communities or underserved populations. Such as will women be enrolled in this trial? So, that is key to addressing questions about disparate populations and equal opportunities for participation. Thus a grant application will be evaluated based on these rules.Academic Mentors Help Navigate The Equity Space For Young Physicians Of course, many aspiring doctors do not attend the top rated University Medical School Programs, many of which are Ivy League schools. Many of the students who attend medical school programs at smaller schools may face unique challenges in their attempts to specialize in lung cancer research. And, the challenges are even greater for students from underrepresented minority groups. However, there is a misperception that investigative science and research only occurs at the Ivy League level. That misperception is not amongst researchers throughout this country and others, but mainly in the lay population. Looking at all National Cancer Institute Comprehensive Designated Cancer Centers, there are over 40 research universities. The majority of these facilities do not reside within the Ivy League environment. Look at the hundreds and hundreds of millions of dollars of research funds that goes into funding research, both in the public and private sector. The vast majority goes into other institutions, that include UC Davis Health and Johns Hopkins Medical Center. The key here is, if you are an individual, especially a person from an underrepresented medicine background, it's important to establish an academic mentor. Especially important, finding someone who introduces you to the scientific method from an early age. Then guides you through a proper development pathway to understanding investigated research.Academic Mentors and Research Funding There are also underutilized funding resources. Typically, resources may be underutilized because many people aren't aware of them. ​​Dr. Christian Rolfo stresses that it’s very important that mentees to be very proactive. “Because if you are sitting there, even if you are coming from a big institution you are sitting there and you don't take the opportunities, nobody will knock your door.” Dr. Cooke believes the key is cross demographic mentorship. An academic mentor doesn't have to look like you or come from the same background, or even quite frankly be in the same political persuasion. But they have to have faith in your abilities, and their only goal in mentoring you, is seeing your success. For example Dr. Cooke cited one of his earliest academic mentors, Dr. Marion Katchlin. “She was older, I was younger, she was wealthy, I was not. She was a smoker, I wasn't. But we both loved immunology. And she took a specific interest in my career, and she taught me that I shouldn't limit myself in any way, and I should strive for the best in any opportunity I want to strive for.” Resources <ul><li><a href="https://www.youtube.com/watch?v=-31IvcY7hoM&amp;t=19s" rel="nofollow" target="_blank">How an LCFA/IASLC Grant Benefits Lung Cancer Research</a></li> <li><a href="https://lcfamerica.org/lung-cancer-research/" rel="nofollow" target="_blank">LCFA Research Grants</a></li> <li><a href="https://www.youtube.com/watch?v=4qQRs2Lf0Sc&amp;ab_channel=LungCancerFoundationofAmerica" rel="nofollow" target="_blank">How to find funding for lung cancer research</a></li></ul>

Academic Mentors, Peers, and Friendtors Make the Difference

In this Hope With Answers podcast, hear from doctors in the field and researchers on the front lines discuss the disparities in lung cancer clinical trials. Disparities in access to healthcare opportunities occur when there is an absence of health equity. These health differences are closely linked with social, economic, and/or environmental disadvantage. Listen to these lung cancer experts address disparity in all aspects. This includes eligibility, referral programs, healthcare access, and appropriate follow-up for lung cancer screening. They propose strategies to address each of these areas so that we can bridge this disparity, equity and inclusion gap.Missing Out on Treatments: Disparities in Lung Cancer Clinical TrialsAdvances in lung cancer treatments over the last few years have made it possible to live with lung cancer for years after diagnosis. But minority and ethnic populations represent less than 5% of those getting the latest treatments in clinical trials. Guests Dr. Raymond Osarogiagbon of Baptist Cancer Center in Memphis, Tennessee Vincent K. Lam, M.D., an Assistant Professor of Oncology at Johns Hopkins, is a clinical/translational investigator with a special interest in lung cancer and an LCFA Young Investigator grantee. Dr. Triparna Sen, is an Assistant Attending, Department of Medicine, Memorial Sloan Kettering Cancer Center; Assistant Professor, Weil Cornell School of Medicine and an LCFA Young Investigator grantee Show Notes | Transcription Patients have the power to make a difference in health disparities in lung cancer clinical trials by: educating themselves on the steps to take asking their doctors questions looking for information on websites like lcfamerica.org or social media oncogene groups.

In this Hope With Answers podcast, hear from doctors in the field and researchers on the front lines discuss the disparities in lung cancer clinical trials. Disparities in access to healthcare opportunities occur when there is an absence of health equity. These health differences are closely linked with social, economic, and/or environmental disadvantage. Listen to these lung cancer experts address disparity in all aspects. This includes eligibility, referral programs, healthcare access, and appropriate follow-up for lung cancer screening. They propose strategies to address each of these areas so that we can bridge this disparity, equity and inclusion gap.Missing Out on Treatments: Disparities in Lung Cancer Clinical Trials Advances in lung cancer treatments over the last few years have made it possible to live with lung cancer for years after diagnosis. But minority and ethnic populations represent less than 5% of those getting the latest treatments in clinical trials. Guests <a href="https://www.baptistcancercenter.com/find-a-doctor/raymond-u-osarogiagbon-md" rel="nofollow" target="_blank">Dr. Raymond Osarogiagbon</a> of Baptist Cancer Center in Memphis, Tennessee <a href="https://lcfamerica.org/research-grants/grants/awarded/vincent-lam-md-johns-hopkins-university/" rel="nofollow" target="_blank">Vincent K. Lam, M.D.</a>, an Assistant Professor of Oncology at Johns Hopkins, is a clinical/translational investigator with a special interest in lung cancer and an LCFA Young Investigator grantee. <a href="https://lcfamerica.org/research-grants/improving-small-cell-lung-cancer-life-expectancy/" rel="nofollow" target="_blank">Dr. Triparna Sen,</a> is an Assistant Attending, Department of Medicine, Memorial Sloan Kettering Cancer Center; Assistant Professor, Weil Cornell School of Medicine and an LCFA Young Investigator grantee <a href="https://lcfamerica.org/wp-content/uploads/2021/10/HWA-21-8-Disparities-in-Lung-Cancer-Clinical-Trials-Show-Notes-Google-Docs.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/10/Disparities-in-Lung-Cancer-Clinical-Trials-Transcrpt.pdf" rel="nofollow" target="_blank">Transcription</a> Patients have the power to make a difference in health disparities in lung cancer clinical trials by: <ul><li>educating themselves on the steps to take</li> <li>asking their doctors questions</li> <li>looking for information on websites like <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a> or social media oncogene groups.</li></ul>

Disparities in Lung Cancer Clinical Trials: Moving toward Equity and Inclusion

What if your lung cancer doctor could get a huge amount of information about your health, how you might respond to different treatments, and possibly even be able to tell you the best diet for your specific needs, all based on a simple test that involves no needles, no surgery, no special preparation, just a small sample… of your stool. That’s the potential of studying the gut microbiome. Find out why some of LCFA’s Young Investigators are so excited about including the gut microbiome in the fight against lung cancer. Guests Dr. Jarushka Naidoo Dr. Daniel Spakowicz Dr. Zoltan Loinai Dr. David Carbone, The Ohio State University Show Notes | TranscriptionGetting over the ick factor: Talking about poopThe immune effect of the microbiome on lung cancer may be due to specific compositions of both lung and gut microbiomes. Three of LCFA’s Young Investigator grant recipients are continuing this study of gut microbiome and lung cancer, Dr. Jarushka Naidoo, Dr. Daniel Spakowicz, and Dr. Zoltan Lohinai.The Future is Gut Microbiomes, Icky As it May BeDiscovering whether a patient’s gut health plays a role in determining the benefits – or, conversely, the harm – of immunotherapy treatment. Until now, there has been scant research connecting gut health with both cancer diagnoses and treatment protocols. The LCFA Young Investigator Grants are designed to help researchers look at lung cancer in new and creative ways, always with an eye toward finding better treatments that help people live longer and healthier lives.Familiarizing the practicing clinician with the experimental methods used to generate the information that will likely impact the field of lung cancer, helping to understand gut microbiome in lung cancer treatment. As Dr. Daniel Spakowicz says, “in general, collecting somebody’s poop before they start a treatment is not a commonly done practice right now, and it tends to be sort of icky to some people. And that’s the essence of what we want to change.”

What if your lung cancer doctor could get a huge amount of information about your health, how you might respond to different treatments, and possibly even be able to tell you the best diet for your specific needs, all based on a simple test that involves no needles, no surgery, no special preparation, just a small sample… of your stool. That’s the potential of studying the gut microbiome. Find out why some of LCFA’s Young Investigators are so excited about including the gut microbiome in the fight against lung cancer. Guests <a href="https://lcfamerica.org/research-grants/precision-medicine-and-lung-cancer/" rel="nofollow" target="_blank">Dr. Jarushka Naidoo</a> <a href="https://lcfamerica.org/research-grants/grants/awarded/dr-daniel-j-spakowicz/" rel="nofollow" target="_blank">Dr. Daniel Spakowicz</a> <a href="https://lcfamerica.org/research-grants/grants/awarded/dr-zoltan-lohinai/" rel="nofollow" target="_blank">Dr. Zoltan Loinai</a> <a href="https://lcfamerica.org/about/advisory/board/dr-david-carbone-m-d-ph-d/" rel="nofollow" target="_blank">Dr. David Carbone</a>, <a href="https://cancer.osu.edu/find-a-doctor/search-physician-directory/david-p-carbone" rel="nofollow" target="_blank">The Ohio State University</a> <a href="https://mk0lcfamerica27gkeby.kinstacdn.com/wp-content/uploads/2021/10/Understanding-gut-microbiome-show-note.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://mk0lcfamerica27gkeby.kinstacdn.com/wp-content/uploads/2021/10/Understanding-gut-microbiome-transcript.pdf" rel="nofollow" target="_blank">Transcription</a>Getting over the ick factor: Talking about poop The immune effect of the microbiome on lung cancer may be due to specific compositions of both lung and gut microbiomes. Three of <a href="https://lcfamerica.org/research-grants/grants/" rel="nofollow" target="_blank">LCFA’s Young Investigator grant recipients</a> are continuing this study of gut microbiome and lung cancer, Dr. Jarushka Naidoo, Dr. Daniel Spakowicz, and Dr. Zoltan Lohinai.The Future is Gut Microbiomes, Icky As it May Be Discovering whether a patient’s gut health plays a role in determining the benefits – or, conversely, the harm – of immunotherapy treatment. Until now, there has been scant research connecting gut health with both cancer diagnoses and treatment protocols. The LCFA Young Investigator Grants are designed to help researchers look at lung cancer in new and creative ways, always with an eye toward finding better treatments that help people live longer and healthier lives.Familiarizing the practicing clinician with the experimental methods used to generate the information that will likely impact the field of lung cancer, helping to understand gut microbiome in lung cancer treatment. As Dr. Daniel Spakowicz says, “in general, collecting somebody’s poop before they start a treatment is not a commonly done practice right now, and it tends to be sort of icky to some people. And that’s the essence of what we want to change.”

Understanding Gut Microbiome in Lung Cancer Treatment

It's no secret that lung cancer affects a patient's entire community: family, friends, co-workers and more. Learning to live with lung cancer is its own challenge, especially for men. Hear from three guys who found their own patient voice, and help others find theirs, as they tackle living with lung cancer in unique and powerful ways. Guests: AJ Patel, James Hiter, and Frank McKenna  Show Notes | TranscriptionAccepting the Challenges As Men Living with Lung CancerAJ Patel, James Hiter, and Frank McKenna have been living with lung cancer for a number of years. Thanks to research and new treatments, they have the experience and commitment to help others facing the same shocking diagnosis. However, they each have unique journeys and different approaches mentally. AJ, James, and Frank are part of LCFA’s Speakers Bureau. They are using their voice to get the word out there for more lung cancer research. They have shared their story on the LCFA’s website, participated in fundraising events and appeared on some of the podcasts to let people know that there are other guys out here that are willing to help other men living with lung cancer.

It's no secret that lung cancer affects a patient's entire community: family, friends, co-workers and more. Learning to live with lung cancer is its own challenge, especially for men. Hear from three guys who found their own patient voice, and help others find theirs, as they tackle living with lung cancer in unique and powerful ways. Guests: <a href="https://lcfamerica.org/lung-cancer-info/survivors/lung-cancer-hope/" rel="nofollow" target="_blank">AJ Patel</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/symptom-free-lung-cancer-diagnosis/" rel="nofollow" target="_blank">James Hiter</a>, and <a href="https://lcfamerica.org/lung-cancer-info/survivors/cough-and-lung-cancer/" rel="nofollow" target="_blank">Frank McKenna</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/09/HWA-EP-21-10-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/09/LCFA-Podcast-Transcript-HWA-EP-21-10.pdf" rel="nofollow" target="_blank">Transcription</a>Accepting the Challenges As Men Living with Lung Cancer <a href="https://lcfamerica.org/lung-cancer-info/survivors/lung-cancer-hope/" rel="nofollow" target="_blank">AJ Patel</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/symptom-free-lung-cancer-diagnosis/" rel="nofollow" target="_blank">James Hiter</a>, and <a href="https://lcfamerica.org/lung-cancer-info/survivors/cough-and-lung-cancer/" rel="nofollow" target="_blank">Frank McKenna</a> have been living with lung cancer for a number of years. Thanks to research and new treatments, they have the experience and commitment to help others facing the same shocking diagnosis. However, they each have unique journeys and different approaches mentally. AJ, James, and Frank are part of <a href="https://newsroom.lcfamerica.org/" rel="nofollow" target="_blank">LCFA’s Speakers Bureau</a>. They are using their voice to get the word out there for more lung cancer research. They have shared their story on the LCFA’s website, participated in fundraising events and appeared on some of the podcasts to let people know that there are other guys out here that are willing to help other men living with lung cancer.

Men living with lung cancer: Finding Their Voice While They Tackle the Taboo

Un diagnóstico de cáncer de pulmón casi requiere aprender un nuevo idioma. En este episodio, usted empezará a escuchar términos como biomarcadores, inmunoterapia y oncólogo torácico. Primero escuche al médico Dr. Christian Rolfo que es experto en el cáncer del pulmón, sobre cómo un paciente puede empezar a desarrollar conceptos y vocabulario muy diferente. Después, escucharás el testimonio de personas que han estado exactamente dónde usted está ahora y como aprender “hablar cáncer.”   Guests Dr. Christian Rolfo - Dr. Christian Rolfo es Oncólogo Torácico y experto en oncología molecular, biopsias líquidas y desarrollo de nuevos fármacos en el ámbito de cáncer de pulmón y mesotelioma en el centro de Oncología Torácica de Mount Sinai. Yovana Portillo, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores Juanita Segura, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores   Recursos Los primeros 7 pasos que debe seguir después de un diagnóstico de cáncer de pulmón   Notas del Programa | Transcripción   La misión de LCFA es mejorar la supervivencia de los pacientes con cáncer de pulmón mediante la financiación de la ciencia transformadora. Mientras recauda fondos para apoyar la investigación del cáncer de pulmón, LCFA aumentará la conciencia del público y servirá como un recurso para los pacientes o cualquier persona que busque respuestas, esperanza y acceso a información actualizada sobre tratamientos, investigaciones científicas y ensayos clínicos.   Usted también puede unirse a la conversación con LCFA en Facebook, Twitter, e Instagram. 

Un diagnóstico de cáncer de pulmón casi requiere aprender un nuevo idioma. En este episodio, usted empezará a escuchar términos como biomarcadores, inmunoterapia y oncólogo torácico. Primero escuche al médico Dr. Christian Rolfo que es experto en el cáncer del pulmón, sobre cómo un paciente puede empezar a desarrollar conceptos y vocabulario muy diferente. Después, escucharás el testimonio de personas que han estado exactamente dónde usted está ahora y como aprender “hablar cáncer.” Guests Dr. Christian Rolfo - Dr. Christian Rolfo es Oncólogo Torácico y experto en oncología molecular, biopsias líquidas y desarrollo de nuevos fármacos en el ámbito de cáncer de pulmón y mesotelioma en el centro de <a href="https://icahn.mssm.edu/research/tisch" rel="nofollow" target="_blank">Oncología Torácica de Mount Sinai</a>. <a href="https://lcfamerica.org/lung-cancer-info/survivors/ned-cancer-yovanas-story/" rel="nofollow" target="_blank">Yovana Portillo</a>, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores <a href="https://lcfamerica.org/lung-cancer-info/survivors/living-with-lung-cancer/" rel="nofollow" target="_blank">Juanita Segura</a>, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores Recursos <a href="https://lcfamerica.org/lung-cancer-info/hope-with-answers-podcast/first-7-steps/" rel="nofollow" target="_blank">Los primeros 7 pasos que debe seguir después de un diagnóstico de cáncer de pulmón</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/07/HWA-Los-Primeros-Siete-Di%CC%81as-Ep-2-Notas-del-Programa.pdf" rel="nofollow" target="_blank">Notas del Programa</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/08/LCFA-HWA-Spanish-2-transctiption.pdf" rel="nofollow" target="_blank">Transcripción</a> La misión de LCFA es mejorar la supervivencia de los pacientes con cáncer de pulmón mediante la financiación de la ciencia transformadora. Mientras recauda fondos para apoyar la investigación del cáncer de pulmón, LCFA aumentará la conciencia del público y servirá como un recurso para los pacientes o cualquier persona que busque respuestas, esperanza y acceso a información actualizada sobre tratamientos, investigaciones científicas y ensayos clínicos.   Usted también puede unirse a la conversación con LCFA en <a href="https://www.facebook.com/lungcancerfoundation/" rel="nofollow" target="_blank">Facebook</a>, <a href="https://twitter.com/lcfamerica" rel="nofollow" target="_blank">Twitter</a>, e <a href="https://www.instagram.com/lcfamerica/" rel="nofollow" target="_blank">Instagram</a>.

Los Primeros Siete Días - ¿Hablas cáncer? Aprender un nuevo vocabulario sobre el cáncer de pulmón

Este programa está diseñado para ayudarles a responder algunas de las preguntas más importantes que surgen inmediatamente después de un diagnóstico. Escucharás el testimonio de personas que han estado exactamente dónde usted está ahora y están viviendo y disfrutando la vida aun con cáncer de pulmón. Ellos serán sus guías a lo largo de la primera parte de su viaje contra el cáncer que estamos llamando Los Primeros Siete Días. Guests Dr. Christian Rolfo - Dr. Christian Rolfo es Oncólogo Torácico y experto en oncología molecular, biopsias líquidas y desarrollo de nuevos fármacos en el ámbito de cáncer de pulmón y mesotelioma en el centro de Oncología Torácica de Mount Sinai. Yovana Portillo, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores Juanita Segura, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores Recursos Los primeros 7 pasos que debe seguir después de un diagnóstico de cáncer de pulmón   Notas del Programa | Transcripción   La misión de LCFA es mejorar la supervivencia de los pacientes con cáncer de pulmón mediante la financiación de la ciencia transformadora. Mientras recauda fondos para apoyar la investigación del cáncer de pulmón, LCFA aumentará la conciencia del público y servirá como un recurso para los pacientes o cualquier persona que busque respuestas, esperanza y acceso a información actualizada sobre tratamientos, investigaciones científicas y ensayos clínicos.   Usted también puede unirse a la conversación con LCFA en Facebook, Twitter, e Instagram. 

Este programa está diseñado para ayudarles a responder algunas de las preguntas más importantes que surgen inmediatamente después de un diagnóstico. Escucharás el testimonio de personas que han estado exactamente dónde usted está ahora y están viviendo y disfrutando la vida aun con cáncer de pulmón. Ellos serán sus guías a lo largo de la primera parte de su viaje contra el cáncer que estamos llamando Los Primeros Siete Días. Guests Dr. Christian Rolfo - Dr. Christian Rolfo es Oncólogo Torácico y experto en oncología molecular, biopsias líquidas y desarrollo de nuevos fármacos en el ámbito de cáncer de pulmón y mesotelioma en el centro de <a href="https://icahn.mssm.edu/research/tisch" rel="nofollow" target="_blank">Oncología Torácica de Mount Sinai</a>. <a href="https://lcfamerica.org/lung-cancer-info/survivors/ned-cancer-yovanas-story/" rel="nofollow" target="_blank">Yovana Portillo</a>, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores <a href="https://lcfamerica.org/lung-cancer-info/survivors/living-with-lung-cancer/" rel="nofollow" target="_blank">Juanita Segura</a>, Sobreviviente de Cancer de Pulmon, LCFA Mesa de Oradores Recursos <a href="https://lcfamerica.org/lung-cancer-info/hope-with-answers-podcast/los-primeros-siete-pasos/" rel="nofollow" target="_blank">Los primeros 7 pasos que debe seguir después de un diagnóstico de cáncer de pulmón</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/07/HWA-Los-Primeros-Siete-Di%CC%81as-Ep-1-Notas-del-Programa.pdf" rel="nofollow" target="_blank">Notas del Programa</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/07/HWA_Los_primeros_7_pasos_Ep1_transcripcio%CC%81n.pdf" rel="nofollow" target="_blank">Transcripción</a> La misión de LCFA es mejorar la supervivencia de los pacientes con cáncer de pulmón mediante la financiación de la ciencia transformadora. Mientras recauda fondos para apoyar la investigación del cáncer de pulmón, LCFA aumentará la conciencia del público y servirá como un recurso para los pacientes o cualquier persona que busque respuestas, esperanza y acceso a información actualizada sobre tratamientos, investigaciones científicas y ensayos clínicos.   Usted también puede unirse a la conversación con LCFA en <a href="https://www.facebook.com/lungcancerfoundation/" rel="nofollow" target="_blank">Facebook</a>, <a href="https://twitter.com/lcfamerica" rel="nofollow" target="_blank">Twitter</a>, e <a href="https://www.instagram.com/lcfamerica/" rel="nofollow" target="_blank">Instagram</a>.

Los Primeros Siete Días - Cómo obtener el diagnóstico correcto

Find out what you need to know for your personal lung cancer journey through stories and interviews with patients, lung cancer specialists, and key participants in the quest for a cure.

If you had to guess what a personal trainer, a die-hard runner, and a healthful vegetarian have in common, you would probably never guess "lung cancer." But far more than their diagnosis, these three guys are connected by the strength they find in their families, the openness and vulnerability they share in talking about their diagnosis, and the focus they put on reaching other men who, like them, are also learning how to live with lung cancer.  Guests: Speakers Bureau members James Hiter, Frank McKenna, and AJ Patel Jim Baranski, Executive Director  Show Notes | TranscriptionSharing Their Lung Cancer DiagnosisGuys DO want and need to share their feelings about the challenges of living with lung cancer. Listen to these poignant stories of James Hiter, Frank McKenna, and AJ Patel. These guys, living with lung cancer, are first and foremost, husbands and fathers. They talk about the strength they draw from the most fundamental relationships in their lives. They talked about sharing their lung cancer diagnosis with their kids—and how those relationships helped change their perception of being diagnosed with lung cancer. AJ Patel talks about how communicating honestly about these issues with his kids helps them work through their own feelings about his diagnosis.Appreciating Their Support NetworkA lung cancer diagnosis is a stressful experience in a person's life. The support of family and friends is incredibly helpful and appreciated by these men, even if they were reluctant at first. Frank shares how the actions of his sons were just so inspiring to him.  “To know that I had that effect on them, that they wanted to give back to me and, and, you know, make their dreams and wishes come true with the little time that we had.”  Since AJ’s diagnosis, he is now more open to family members and others talking to them and sharing his emotions and feelings. This openness was something new - he was reserved and never really talked about his health because he thought he was supposed to be the head of the household. “What am I going to do? Being vulnerable? But now I realize that vulnerability leads to discussions and dialogues, and it's not necessarily always an outcome that we're, well, now we feel better.” AJ has stepped up to connect as a “buddy” to other men facing a lung cancer diagnosis.  “I would just encourage if anybody's listening to this and you've been recently diagnosed, you know, somebody has been recently diagnosed, set aside, whatever preconceived ideas you have about talking to people that you don't know about this, and just know it can be really beneficial just to have a second set of ears.”Men Also Advocate for Lung Cancer ResearchAnother thing that all three men have in common is the knowledge that the latest lung cancer research has been vital to their survival of this disease. Knowing that there is much more work to be done, they have chosen different ways to advocate for lung cancer research. Besides being part of the LCFA’s Speakers Bureau, each of them found a way to give back even while managing their own cancer journey. “And it's, it's so important for guys to know that there were other guys in here, you know, like the three of us who work with the speaker's bureau in order to get that word out there. And do the events that we do - appear on some of the podcasts and on the websites, and some of the things we do to let people know that there were other guys out here that are willing to help, they're willing to, you know, either lead by example or give advice, or, you know, just kind of say, it's okay to talk to someone who knows what you're going through or has been through it.” - Frank McKenna James also shares an important message: “My hope is that you will be inspired to spread the word. It’s time for this disease to be funded and treated like all other types of cancer. It's time for the world to know that if you have lungs, you can get lung cancer- smoker, non-smoker or never-smoker.” 

If you had to guess what a personal trainer, a die-hard runner, and a healthful vegetarian have in common, you would probably never guess "lung cancer." But far more than their diagnosis, these three guys are connected by the strength they find in their families, the openness and vulnerability they share in talking about their diagnosis, and the focus they put on reaching other men who, like them, are also learning how to live with lung cancer.  Guests: Speakers Bureau members James Hiter, Frank McKenna, and AJ Patel Jim Baranski, Executive Director  <a href="https://lcfamerica.org/wp-content/uploads/2021/06/HWA-EP-21-5-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/06/LCFA-EP-21-5-Show-Notes.pdf" rel="nofollow" target="_blank">Transcription</a>Sharing Their Lung Cancer Diagnosis Guys DO want and need to share their feelings about the challenges of living with lung cancer. Listen to these poignant stories of James Hiter, Frank McKenna, and AJ Patel. These guys, living with lung cancer, are first and foremost, husbands and fathers. They talk about the strength they draw from the most fundamental relationships in their lives. They talked about sharing their lung cancer diagnosis with their kids—and how those relationships helped change their perception of being diagnosed with lung cancer. AJ Patel talks about how communicating honestly about these issues with his kids helps them work through their own feelings about his diagnosis.Appreciating Their Support Network A lung cancer diagnosis is a stressful experience in a person's life. The support of family and friends is incredibly helpful and appreciated by these men, even if they were reluctant at first. Frank shares how the actions of his sons were just so inspiring to him.  “To know that I had that effect on them, that they wanted to give back to me and, and, you know, make their dreams and wishes come true with the little time that we had.”  Since AJ’s diagnosis, he is now more open to family members and others talking to them and sharing his emotions and feelings. This openness was something new - he was reserved and never really talked about his health because he thought he was supposed to be the head of the household. “What am I going to do? Being vulnerable? But now I realize that vulnerability leads to discussions and dialogues, and it's not necessarily always an outcome that we're, well, now we feel better.” AJ has stepped up to connect as a “buddy” to other men facing a lung cancer diagnosis.  “I would just encourage if anybody's listening to this and you've been recently diagnosed, you know, somebody has been recently diagnosed, set aside, whatever preconceived ideas you have about talking to people that you don't know about this, and just know it can be really beneficial just to have a second set of ears.”Men Also Advocate for Lung Cancer Research Another thing that all three men have in common is the knowledge that the latest lung cancer research has been vital to their survival of this disease. Knowing that there is much more work to be done, they have chosen different ways to advocate for lung cancer research. Besides being part of the LCFA’s Speakers Bureau, each of them found a way to give back even while managing their own cancer journey. “And it's, it's so important for guys to know that there were other guys in here, you know, like the three of us who work with the speaker's bureau in order to get that word out there. And do the events that we do - appear on some of the podcasts and on the websites, and some of the things we do to let people know that there were other guys out here that are willing to help, they're willing to, you know, either lead by example or give advice, or, you know, just kind of say, it's okay to talk to someone who knows what you're going through or has been through it.” - Frank McKenna James also shares an important message: “My hope is that you will be inspired to spread the word. It’s time for this disease to be funded and treated like all other types of cancer. It's time for the world to know that if you have lungs, you can get lung cancer- smoker, non-smoker or never-smoker.”

Who Says Men Can Only Talk Sports?

Living with lung cancer is never easy, but finding your lung cancer tribe with other patient advocates can help newly-diagnosed patients harness the power of their own voice in treatment. Hear from LCFA's group of patient advocates about how they got connected through patient groups that helped them learn how to navigate the lung cancer journey. You'll also hear from lung cancer specialist Dr. Raymond Osarogiagbon of Baptist Cancer Center in Memphis, who shares his hopes for the future of lung cancer treatment. Guests: Dr. Raymond Osarogiagbon of Baptist Cancer Center in Memphis, Tennessee LCFA Speakers Bureau members Terri Conneran, Linnea Olson, Ivy Elkins, Yovana Portillo, AJ Patel, Montessa Lee, Gina Hollenbeck, and Frank McKenna Show Notes | Transcription  Patients Voices Can Change the Shape of ResearchIn lung cancer research, the patient’s voice matters. Patient advocacy can shape research and can impart to the research community the sense of urgency patients deal with every day.“Patients may not realize just how powerful their voice can be in their own lung cancer treatment plan or in helping others through their journey.” - Kim NorrisThere has been a real change in lung cancer research that's just happened over the last 10 years or so. When Kim Norris, LCFA’s co-founder and President, first got into lung cancer patient advocacy years ago, the treatments available and the survival rates were not encouraging. Now, there's so many reasons for newly diagnosed patients to be hopeful. Although 5, 10, even 15 years doesn't sound like a long time, in lung cancer research, it's an eternity. More new treatments have been approved in the past five years than have been approved in the last 20 combined. And new discoveries are continually happening at such a rapid pace that is sometimes hard to keep up with them all. Thoracic oncologist Dr. Raymond Osarogiagbon is encouraged by the power of the patient's voice to explain what it means to be living with lung cancer. “We are making a lot of progress in lung cancer, and that is true. And that progress has come very quickly. It seems like literally every few weeks, every few months, there's a new groundbreaking discovery.”LCFA’s Speakers Bureau Discuss Finding Their TribesAt this year’s annual get-together (held virtually) the LCFA’s Speakers Bureau talked about the power of finding your tribe, finding lung cancer patients who share the same experience, and sometimes even the same biomarker. This shared experience often helps newly diagnosed patients find their own voice to advocate for the best treatment plan. As more people are living longer, healthier lives with lung cancer, many find meaning in advocating for others, helping newly diagnosed patients know the right test to get, and the right questions to ask to be part of their own treatment plans.How Patients and Their Tribes Use Their VoicesSome turn their advocacy into activism, lobbying for increased lung cancer funding, and raising awareness of lung cancer as the number one cancer killer. Terri Conneran is very actively using her voice by serving on lung cancer advocacy boards, working on events, supporting various foundations, and maintaining a voice for lung cancer patients online.“Those of us in the lung cancer community are living with this silent disease growing within us and we need to give it a voice. If I can help one person, my goal is met.” - Terri ConneranIvy Elkins has completed Advocate Training through the American Association of Cancer Research. She then created and moderates two Facebook groups – close to 500 members strong – where they share information regarding clinical trials and treatments. Their primary goal is to work as a group to get the attention of lung cancer researchers. However, simply finding a support group is an excellent first step.The Importance of Finding Your Lung Cancer TribeMembers of the LCFA Speakers Bureau share what it means to be living with lung cancer. Some advocates use their anger, frustration, and sadness as motivation for their advocacy. Frank McKenna thinks it's important that lung cancer patients stay involved in things like helping other people.“Even if we don't personally reach out and need that help, I think so many people rely on our experiences and they reach out to us. It's just, I think it's been very rewarding to me when somebody says you've been a godsend because you've given me this information, I can't get it anywhere else.”Voicing the Pros and Cons of Using “Dr. Google”Kim Norris agrees that finding and connecting with other lung cancer patients is much easier today. Patient groups can help them find the right questions to ask and the right test to have done.“Thanks, of course, to a quick Google search. But it helps to know what you’re searching for. Searches like lung cancer survivor stories or KRAS patient groups will generally lead to useful and actionable information that can help patients connect to others going through the same experience, as advocate Terri Conneran learned.”Terri Conneran’s doctor told her to stay off of Google because she's going to see nothing but bad news. Connecting with a local lung cancer group, she learned more about individual biomarkers like EGFR and ALK. This knowledge led to her questioning her doctor regarding biomarkers and the discovery that her cancer has the KRAS biomarker. Speaker Ivy Elkins did a Google search, even though her doctor warned her against that. But she looked for blogs and other people experiencing similar life situations. Yovana Portilla also did a Google search looking for “lung cancer support group” to find other people that have been through this before me for advice along her lung cancer journey.Other Ways To Advocate for Lung Cancer ResearchNot all lung cancer patients can devote unlimited time to reading journal articles, understanding clinical trial design, and communicating effectively with scientists and physicians. However, there are some effective ways to advocate right from your home. Build a network of support with family members, friends, community members, and fellow advocates living with lung cancer. Find an online community. There are more specific communities advocating for specific lung cancer biomarkers. These are some of the biomarker communities our Speakers Bureau participate in: EGFR Resisters ALK Fusion Facebook Group ALK Positive The ROS1ders KRASkickers  There has never been a more important time for the U.S. to invest in medical research. Thanks to bipartisan support in Congress, the National Institutes of Health (NIH) has received significant funding increases for the last six years. Monitor important legislation for lung cancer research. On the National Cancer Institute website there are summaries of legislation proposed affecting federal health policy. This page is updated as relevant legislation is introduced. Then contact your Congressional representatives. Ask them to make sustained funding for lung cancer research a national priority starting with funding important lung cancer research policies currently up for legislative approval. Watch lung cancer patient and advocate Gina Hollenbeck discuss the importance of turning up the volume of the patient’s voice.Other Legislative ResourcesNIH Office of Legislative Policy and Analysis (OLPA) - this office is the liaison between NIH and Congress National Conference of State Legislatures - Cancer-Specific State Legislation - where you can find information on cancer-specific state legislation National Conference of State Legislatures - Health-Related State Legislation - where you can find information on health-related state legislation Kaiser Family Foundation - this foundation provides state-specific information related to cancer and healthFinding your lung cancer tribe can be your key toGetting the best information on your specific lung cancer and the best treatment options Connecting with a support group of people who know EXACTLY what you’re going through Making the lung cancer journey of someone coming behind you easier

Living with lung cancer is never easy, but finding your lung cancer tribe with other patient advocates can help newly-diagnosed patients harness the power of their own voice in treatment. Hear from LCFA's group of patient advocates about how they got connected through patient groups that helped them learn how to navigate the lung cancer journey. You'll also hear from lung cancer specialist Dr. Raymond Osarogiagbon of Baptist Cancer Center in Memphis, who shares his hopes for the future of lung cancer treatment. Guests: <a href="https://www.baptistcancercenter.com/find-a-doctor/raymond-u-osarogiagbon-md" rel="nofollow" target="_blank">Dr. Raymond Osarogiagbon</a> of Baptist Cancer Center in Memphis, Tennessee LCFA Speakers Bureau members <a href="https://lcfamerica.org/lung-cancer-info/survivors/diagnosis-asthma-or-lung-cancer/" rel="nofollow" target="_blank">Terri Conneran</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/lung-cancer-patients-live-longer/" rel="nofollow" target="_blank">Linnea Olson</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/advocating-lung-cancer-research/" rel="nofollow" target="_blank">Ivy Elkins</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/ned-cancer-yovanas-story/" rel="nofollow" target="_blank">Yovana Portillo</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/lung-cancer-hope/" rel="nofollow" target="_blank">AJ Patel</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/small-cell-lung-cancer/" rel="nofollow" target="_blank">Montessa Lee</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/alk-positive-lung-cancer/" rel="nofollow" target="_blank">Gina Hollenbeck</a>, and <a href="https://lcfamerica.org/lung-cancer-info/survivors/cough-and-lung-cancer/" rel="nofollow" target="_blank">Frank McKenna</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/05/Episode-21-4-Show-Notes-finding-your-lung-cancer-tribe.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/05/LCFA-Podcast-EP-21-4-Transcript.pdf" rel="nofollow" target="_blank">Transcription</a>  Patients Voices Can Change the Shape of Research In lung cancer research, the patient’s voice matters. Patient advocacy can shape research and can impart to the research community the sense of urgency patients deal with every day.“Patients may not realize just how powerful their voice can be in their own lung cancer treatment plan or in helping others through their journey.” - Kim Norris There has been a real change in lung cancer research that's just happened over the last 10 years or so. When Kim Norris, LCFA’s co-founder and President, first got into lung cancer patient advocacy years ago, the treatments available and the survival rates were not encouraging. Now, there's so many reasons for newly diagnosed patients to be hopeful. Although 5, 10, even 15 years doesn't sound like a long time, in lung cancer research, it's an eternity. More new treatments have been approved in the past five years than have been approved in the last 20 combined. And new discoveries are continually happening at such a rapid pace that is sometimes hard to keep up with them all. Thoracic oncologist Dr. Raymond Osarogiagbon is encouraged by the power of the patient's voice to explain what it means to be living with lung cancer. “We are making a lot of progress in lung cancer, and that is true. And that progress has come very quickly. It seems like literally every few weeks, every few months, there's a new groundbreaking discovery.”LCFA’s Speakers Bureau Discuss Finding Their Tribes At this year’s annual get-together (held virtually) the LCFA’s Speakers Bureau talked about the power of finding your tribe, finding lung cancer patients who share the same experience, and sometimes even the same biomarker. This shared experience often helps newly diagnosed patients find their own voice to advocate for the best treatment plan. As more people are living longer, healthier lives with lung cancer, many find meaning in advocating for others, helping newly diagnosed patients know the right test to get, and the right questions to ask to be part of their own treatment plans.How Patients and Their Tribes Use Their Voices Some turn their advocacy into activism, lobbying for increased lung cancer funding, and raising awareness of lung cancer as the number one cancer killer. Terri Conneran is very actively using her voice by serving on lung cancer advocacy boards, working on events, supporting various foundations, and maintaining a voice for lung cancer patients online.“Those of us in the lung cancer community are living with this silent disease growing within us and we need to give it a voice. If I can help one person, my goal is met.” - Terri Conneran Ivy Elkins has completed Advocate Training through the American Association of Cancer Research. She then created and moderates two Facebook groups – close to 500 members strong – where they share information regarding clinical trials and treatments. Their primary goal is to work as a group to get the attention of lung cancer researchers. However, simply <a href="https://lcfamerica.org/resource/smart-patients-lung-cancer-community/" rel="nofollow" target="_blank">finding a support group</a> is an excellent first step.The Importance of Finding Your Lung Cancer Tribe Members of the LCFA Speakers Bureau share what it means to be living with lung cancer. Some advocates use their anger, frustration, and sadness as motivation for their advocacy. Frank McKenna thinks it's important that lung cancer patients stay involved in things like helping other people.“Even if we don't personally reach out and need that help, I think so many people rely on our experiences and they reach out to us. It's just, I think it's been very rewarding to me when somebody says you've been a godsend because you've given me this information, I can't get it anywhere else.” Voicing the Pros and Cons of Using “Dr. Google” Kim Norris agrees that finding and connecting with other lung cancer patients is much easier today. Patient groups can help them find the right questions to ask and the right test to have done.“Thanks, of course, to a quick Google search. But it helps to know what you’re searching for. Searches like lung cancer survivor stories or KRAS patient groups will generally lead to useful and actionable information that can help patients connect to others going through the same experience, as advocate Terri Conneran learned.” Terri Conneran’s doctor told her to stay off of Google because she's going to see nothing but bad news. Connecting with a local lung cancer group, she learned more about individual biomarkers like EGFR and ALK. This knowledge led to her questioning her doctor regarding biomarkers and the discovery that her cancer has the KRAS biomarker. Speaker Ivy Elkins did a Google search, even though her doctor warned her against that. But she looked for blogs and other people experiencing similar life situations. Yovana Portilla also did a Google search looking for “lung cancer support group” to find other people that have been through this before me for advice along her lung cancer journey.Other Ways To Advocate for Lung Cancer Research Not all lung cancer patients can devote unlimited time to reading journal articles, understanding clinical trial design, and communicating effectively with scientists and physicians. However, there are some effective ways to advocate right from your home. Build a network of support with family members, friends, community members, and fellow advocates living with lung cancer. Find an online community. There are more specific communities advocating for specific lung cancer biomarkers. These are some of the biomarker communities our Speakers Bureau participate in: <ul><li><a href="https://egfrcancer.org/" rel="nofollow" target="_blank">EGFR Resisters</a></li> <li><a href="https://www.facebook.com/groups/ALKFusion/" rel="nofollow" target="_blank">ALK Fusion Facebook Group</a></li> <li><a href="https://www.alkpositive.org/" rel="nofollow" target="_blank">ALK Positive</a></li> <li><a href="https://ros1cancer.com/" rel="nofollow" target="_blank">The ROS1ders</a></li> <li><a href="https://www.kraskickers.org/" rel="nofollow" target="_blank">KRASkickers</a></li> </ul> There has never been a more important time for the U.S. to invest in medical research. Thanks to bipartisan support in Congress, the National Institutes of Health (NIH) has received significant funding increases for the last six years. Monitor important legislation for lung cancer research. On the National Cancer Institute website there are summaries of legislation proposed affecting federal health policy. This page is updated as relevant legislation is introduced. Then contact your Congressional representatives. Ask them to make sustained funding for lung cancer research a national priority starting with funding important lung cancer research policies currently up for legislative approval. <a href="https://lcfamerica.org/lung-cancer-info/hope-with-answers/empowering-patient-voice-videos/" rel="nofollow" target="_blank">Watch lung cancer patient and advocate Gina Hollenbeck discuss the importance of turning up the volume of the patient’s voice.</a>Other Legislative Resources <ul><li><a href="https://www.nih.gov/institutes-nih/nih-office-director/olpa" rel="nofollow" target="_blank">NIH Office of Legislative Policy and Analysis (OLPA)</a> - this office is the liaison between NIH and Congress</li> <li><a href="http://www.ncsl.org/research/health/diseases-and-conditions/cancer.aspx" rel="nofollow" target="_blank">National Conference of State Legislatures - Cancer-Specific State Legislation</a> - where you can find information on cancer-specific state legislation</li> <li><a href="http://xn--7ca" rel="nofollow" target="_blank">National Conference of State Legislatures - Health-Related State Legislation</a> - where you can find information on health-related state legislation</li> <li><a href="http://kff.org/search/?s=cancer&amp;tab=data&amp;facets%5Bpost_type%5D%5B%5D=state-indicator" rel="nofollow" target="_blank">Kaiser Family Foundation</a> - this foundation provides state-specific information related to cancer and health</li></ul>Finding your lung cancer tribe can be your key to <ul><li>Getting the best information on your specific lung cancer and the best treatment options</li> <li>Connecting with a support group of people who know EXACTLY what you’re going through</li> <li>Making the lung cancer journey of someone coming behind you easier</li></ul>

Finding Your Lung Cancer Tribe: Tips from Patient Advocates

Annabelle Gurwitch

It’s Not Covid? It’s Lung Cancer?A lung cancer diagnosis was the shocker to the year Annabelle Gurwitch already had going in 2020. She went to have a Covid test and left with a lung cancer diagnosis. She’s an actress, activist, and author of five books including I See You Made an Effort. In 2020, she’d written a new book and started as a co-host on a podcast called Tiny Victories. Now she is sharing her lung cancer diagnosis story - as only Annabelle would, with humor. View Show Notes | TranscriptionWhen Lung Cancer Goes Citrus  When she went to have a cough checked out last year thinking it might be Covid, she came away with the shocking diagnosis of stage IV lung cancer. She is grateful for lung cancer research funding and how she's now using her voice - and relentless sense of humor - as a lung cancer patient advocate. “And then, once they said they found something, there's a tumor, the size of a Clementine. Well, you know, when something goes citrus, you're in trouble.” A biopsy and a diagnosis of stage IV cancer. was more shocking to Annabelle because other than her little cough, she exercised every day and felt like she was in really good health.Non-smokers Get Diagnosed With Lung Cancer?  “What I didn't realize when I was diagnosed, because it had not been on my radar at all, was this growing epidemic of lung cancer in nonsmoking women.” A 2017 study of 12,103 lung cancer patients in three representative U.S. hospitals found that never-smokers were 8% of the total from 1990 to 1995 but 14.9% from 2011 to 2013. The authors concluded that “the actual incidence of lung cancer in never smokers is increasing.” Another study that same year, of 2,170 patients in the U.K., found an even larger increase: The proportion of lung cancer patients who were never-smokers rose from 13% in 2008 to 28% in 2014. It is well-documented that approximately 20% of lung cancer cases that occur in women in the U.S. and 9% of cases in men, are diagnosed in never-smokers. Cigarette smoking is still the single greatest cause of lung cancer. And today’s screening recommendations apply only to current and former smokers. Yet according to a study published in December 2020 in JAMA Oncology,12% of U.S. lung cancer patients are never-smokers.Targeted Treatment for EGFR Mutation in Lung Cancer  Annabelle recognizes that lung cancer research is a key reason her lung cancer diagnosis came with hope. “... because I get to have the life I'm having right now because of the drugs that were developed in the last five years. I happen to have the EGFR Mutation, which responds to a medication that allows me to continue a pretty normal life, except for the extra napping.”Advocating for Lung Cancer Research  “I have some cells that went rogue, and that's how I think about it. One of the hardest times in my life was the three months where I didn't know what I was facing. I have to say there was, at least some relief as weird as that sounds in the diagnosis.” Annabelle’s story of an accidental lung cancer diagnosis is a very common story among lung cancer patients. In Annabelle’s case, getting an accurate diagnosis set her on a treatment course that is manageable as well as saving her life. Now Annabelle is in a position to “pay it forward” by reaching out to others who may benefit from hearing her story. “These drugs will stop working in a certain amount of time and whether I survive and how I survive, what kind of quality of living I have is entirely dependent on lung cancer research funding.” Annabelle is determined as a writer and a storyteller, to share her story, her lung cancer diagnosis, and how she’s living with it and the incredible tight rope she’s now walking. In becoming an advocate for lung cancer research, a story about a lung cancer diagnosis and Annabelle Gurwitch sets the stage for the next chapter in her life.

It’s Not Covid? It’s Lung Cancer? A lung cancer diagnosis was the shocker to the year Annabelle Gurwitch already had going in 2020. She went to have a Covid test and left with a lung cancer diagnosis. She’s an actress, activist, and author of five books including I See You Made an Effort. In 2020, she’d written a new book and started as a co-host on <a href="https://maximumfun.org/podcasts/tiny-victories/" rel="nofollow" target="_blank">a podcast called Tiny Victories</a>. Now she is sharing her lung cancer diagnosis story - as only Annabelle would, with humor. View <a href="https://lcfamerica.org/wp-content/uploads/2021/04/HWA-Ep-21-3-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/04/LCFA-Podcast-Ep-21-3-Transcript.docx.pdf" rel="nofollow" target="_blank">Transcription</a>When Lung Cancer Goes Citrus When she went to have a cough checked out last year thinking it might be Covid, she came away with the shocking diagnosis of stage IV lung cancer. She is grateful for lung cancer research funding and how she's now using her voice - and relentless sense of humor - as a lung cancer patient advocate. “And then, once they said they found something, there's a tumor, the size of a Clementine. Well, you know, when something goes citrus, you're in trouble.” A biopsy and a diagnosis of stage IV cancer. was more shocking to Annabelle because other than her little cough, she exercised every day and felt like she was in really good health.Non-smokers Get Diagnosed With Lung Cancer? “What I didn't realize when I was diagnosed, because it had not been on my radar at all, was this growing epidemic of lung cancer in nonsmoking women.” A 2017 study of 12,103 lung cancer patients in three representative U.S. hospitals found that never-smokers were 8% of the total from 1990 to 1995 but 14.9% from 2011 to 2013. The authors concluded that “the actual incidence of lung cancer in never smokers is increasing.” Another study that same year, of 2,170 patients in the U.K., found an even larger increase: The proportion of lung cancer patients who were never-smokers rose from 13% in 2008 to 28% in 2014. It is well-documented that <a href="https://lcfamerica.org/research-grants/latest/research/but-i-never-smoked-never-smokers-and-lung-cancer/" rel="nofollow" target="_blank">approximately 20% of lung cancer cases that occur in women in the U.S. and 9% of cases in men, are diagnosed in never-smokers</a>. Cigarette smoking is still the single greatest cause of lung cancer. And today’s screening recommendations apply only to current and former smokers. Yet according to a study published in December 2020 in JAMA Oncology,12% of U.S. lung cancer patients are never-smokers.Targeted Treatment for EGFR Mutation in Lung Cancer Annabelle recognizes that lung cancer research is a key reason her lung cancer diagnosis came with hope. “... because I get to have the life I'm having right now because of the drugs that were developed in the last five years. I happen to have the EGFR Mutation, which responds to a medication that allows me to continue a pretty normal life, except for the extra napping.”Advocating for Lung Cancer Research “I have some cells that went rogue, and that's how I think about it. One of the hardest times in my life was the three months where I didn't know what I was facing. I have to say there was, at least some relief as weird as that sounds in the diagnosis.” Annabelle’s story of an accidental lung cancer diagnosis is a very common story among lung cancer patients. In Annabelle’s case, getting an accurate diagnosis set her on a treatment course that is manageable as well as saving her life. Now Annabelle is in a position to “pay it forward” by reaching out to others who may benefit from hearing her story. “These drugs will stop working in a certain amount of time and whether I survive and how I survive, what kind of quality of living I have is entirely dependent on lung cancer research funding.” Annabelle is determined as a writer and a storyteller, to share her story, her lung cancer diagnosis, and how she’s living with it and the incredible tight rope she’s now walking. In becoming an advocate for lung cancer research, a story about a lung cancer diagnosis and Annabelle Gurwitch sets the stage for the next chapter in her life.

Lung Cancer DIagnosis and Annabelle Gurwitch: When Lung Cancer Goes Citrus

The U.S. Preventive Services Task Force has recently changed the guidelines for lung cancer screening. Listen to two experts who helped establish the first set of screening guidelines. Then hear from a patient advocate living with lung cancer on how the change in screening is a step in the right direction. Guests: Dr. Denise Aberle, LCFA Scientific Advisory Board member David Sturges, LCFA Co-founder and lung cancer survivor Terri Conneran, LCFA Speaker Bureau member   Show Notes | Transcription  Establishing the first set of NLST guidelinesThe first NCI-sponsored National Lung Screening Trial (NLST) was a trial to compare two ways of lung cancer screening: low dose helical CT versus chest radiography. The NLST was the joint collaboration of ACRIN and the Lung Screening Study. Dr. Denise Aberle served as the national Principal Investigator of the American College of Radiology Imaging Network (ACRIN-NLST) component of the National Lung Screening Trial. Dr. Aberle’s research also centers on lung cancer and oncologic imaging for response assessment; quantitative image analysis, and oncology informatics. LCFA’s co-founder, David Sturges served on the United States Department of Defense’s Congressionally Directed Medical Research Programs’ Integration Panel. He was the sole patient advocate at the table for the groundbreaking National Lung Screening Trial’s Data and Safety Monitoring Board (DSMB). These new lung cancer screening guidelines have two significant changes to the previous criteria in place regarding who qualifies for annually testing: Lowered the age from 55 to 50 so now the Age Range criteria is now Ages 50 - 77. Changed the pack years smoking calculation from using 30 pack years of smoking to using 20 pack years of smoking.  Although these improved guidelines may lead to more smokers getting tested for lung cancer earlier, there are many factors that might put you at risk for lung cancer. Many people believe that smoking alone causes lung cancer. But, increasingly, people who have never smoked or who quit smoking many years ago are being diagnosed with lung cancer. Hear from Terri Conneran, member of LCFA’s Speakers Bureau, tell her diagnosis story as one who didn’t meet these criteria. Learn more about her road to her specific diagnosis, which did not follow a direct route.Why is the change in screening guidelines important?Besides the statistic that more than half of new lung cancer patients have never smoked or quit more than 15 years ago are not included in the original CT screening recommendations: These revisions will reduce both racial and sex disparities to enable screening in a higher risk groups and additional percentage of the population who we know are going to get lung cancer. They will provide greater benefits in reducing lung cancer mortality across the United States.  When detected early, lung cancer patients have more treatment options and a far greater chance of survival. The 5-year survival rate for those diagnosed before the cancer has spread rises from 18 out of every 100 people to 55 out of every 100. But, the key is being screened for lung cancer early. “The trial lasted from 2002 when we launched to about 2010, and was able over time to identify that low dose CT screening did in fact reduce deaths from lung cancer because of early detection. The name of the game is early detection because that's when the cancer can be treated and is most likely to be curable, meaning to result in long-term survival. And that's exactly what we saw.”  - Dr. Denise Aberle And, even with the new lung cancer screening guidelines, there still is an emphasis on screening people who are either current or former smokers. These guidelines still won’t catch many of the lung cancers in never smoking patients who have a genetic alteration driving their cancer. “While we were talking about smoking and pack-years and all of that, it's true that if you have lungs, you can get lung cancer, right? I mean, you just have to be on top of your health as much as you possibly can. Every breath counts, for sure.” LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

The U.S. Preventive Services Task Force has recently changed the guidelines for lung cancer screening. Listen to two experts who helped establish the first set of screening guidelines. Then hear from a patient advocate living with lung cancer on how the change in screening is a step in the right direction. Guests: <a href="https://lcfamerica.org/about/advisory/board/dr-denise-aberle/" rel="nofollow" target="_blank">Dr. Denise Aberle</a>, LCFA Scientific Advisory Board member <a href="https://lcfamerica.org/about/board/director/david-sturges/" rel="nofollow" target="_blank">David Sturges</a>, LCFA Co-founder and lung cancer survivor <a href="https://lcfamerica.org/lung-cancer-info/survivors/diagnosis-asthma-or-lung-cancer/" rel="nofollow" target="_blank">Terri Conneran</a>, LCFA Speaker Bureau member <a href="https://lcfamerica.org/wp-content/uploads/2021/04/Episode-21-2-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes</a> | <a href="https://lcfamerica.org/wp-content/uploads/2021/04/LCFA_Podcast_HWA_EP_21-2-V2-Transcript.pdf" rel="nofollow" target="_blank">Transcription</a>  Establishing the first set of NLST guidelines The first NCI-sponsored National Lung Screening Trial (NLST) was a trial to compare two ways of lung cancer screening: low dose helical CT versus chest radiography. The NLST was the joint collaboration of ACRIN and the Lung Screening Study. Dr. Denise Aberle served as the national Principal Investigator of the American College of Radiology Imaging Network (ACRIN-NLST) component of the National Lung Screening Trial. Dr. Aberle’s research also centers on lung cancer and oncologic imaging for response assessment; quantitative image analysis, and oncology informatics. LCFA’s co-founder, David Sturges served on the United States Department of Defense’s Congressionally Directed Medical Research Programs’ Integration Panel. He was the sole patient advocate at the table for the groundbreaking National Lung Screening Trial’s Data and Safety Monitoring Board (DSMB). These <a href="https://lcfamerica.org/research-grants/latest/research/lung-cancer-screening/" rel="nofollow" target="_blank">new lung cancer screening guidelines</a> have two significant changes to the previous criteria in place regarding who qualifies for annually testing: <ul><li>Lowered the age from 55 to 50 so now the Age Range criteria is now Ages 50 - 77.</li> <li>Changed the pack years smoking calculation from using 30 pack years of smoking to using 20 pack years of smoking.</li> </ul> Although these improved guidelines may lead to more smokers getting tested for lung cancer earlier, there are many factors that might put you at risk for lung cancer. Many people believe that smoking alone causes lung cancer. But, increasingly, people who have never smoked or who quit smoking many years ago are being diagnosed with lung cancer. Hear from Terri Conneran, member of LCFA’s Speakers Bureau, tell her diagnosis story as one who didn’t meet these criteria. Learn more about her road to her specific diagnosis, which did not follow a direct route.Why is the change in screening guidelines important? Besides the statistic that more than half of new lung cancer patients have never smoked or quit more than 15 years ago are not included in the original CT screening recommendations: <ul><li>These revisions will reduce both racial and sex disparities to enable screening in a higher risk groups and additional percentage of the population who we know are going to get lung cancer.</li> <li>They will provide greater benefits in reducing lung cancer mortality across the United States.</li> </ul> When detected early, lung cancer patients have more treatment options and a far greater chance of survival. The 5-year survival rate for those diagnosed before the cancer has spread rises from 18 out of every 100 people to 55 out of every 100. But, the key is being screened for lung cancer early. “The trial lasted from 2002 when we launched to about 2010, and was able over time to identify that low dose CT screening did in fact reduce deaths from lung cancer because of early detection. The name of the game is early detection because that's when the cancer can be treated and is most likely to be curable, meaning to result in long-term survival. And that's exactly what we saw.”  - Dr. Denise Aberle And, even with the new lung cancer screening guidelines, there still is an emphasis on screening people who are either current or former smokers. These guidelines still won’t catch many of the lung cancers in never smoking patients who have a genetic alteration driving their cancer. “While we were talking about smoking and pack-years and all of that, it's true that if you have lungs, you can get lung cancer, right? I mean, you just have to be on top of your health as much as you possibly can. Every breath counts, for sure.” LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

NEW Lung Cancer Screening Recommendations: What does that mean?

Learn the latest Small Cell Lung Cancer (SCLC) research. Hear from 14-year SCLC patient/advocate for the underdog, Montessa Lee, who took her anger and turned it into advocacy. Listen to lung cancer researcher Dr. Triparna Sen explain how DNA damage repair inhibitors are the “Achilles Heel” of SCLC tumors. Guests:  Montessa Lee: educator, lung cancer patient advocate, 14-year SCLC survivor Dr. Triparna Sen, Memorial Sloan Kettering Cancer Center, New York   Show Notes for this episode Transcript of this episode   LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science. While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials. You can also join the conversation with LCFA on Facebook, Twitter, and Instagram.

Learn the latest Small Cell Lung Cancer (SCLC) research. Hear from 14-year SCLC patient/advocate for the underdog, Montessa Lee, who took her anger and turned it into advocacy. Listen to lung cancer researcher Dr. Triparna Sen explain how DNA damage repair inhibitors are the “Achilles Heel” of SCLC tumors. Guests:  <a href="https://lcfamerica.org/lung-cancer-info/survivors/small-cell-lung-cancer/" rel="nofollow" target="_blank">Montessa Lee</a>: educator, lung cancer patient advocate, 14-year SCLC survivor <a href="https://lcfamerica.org/research-grants/improving-small-cell-lung-cancer-life-expectancy/" rel="nofollow" target="_blank">Dr. Triparna Sen</a>, Memorial Sloan Kettering Cancer Center, New York <a href="https://lcfamerica.org/wp-content/uploads/2021/03/Episode-21-1-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes for this episode</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/03/LCFA_Podcast_HWA_EP_21-1_Transcript.pdf" rel="nofollow" target="_blank">Transcript of this episode</a> LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science. While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials. You can also join the conversation with LCFA on <a href="https://www.facebook.com/lungcancerfoundation/" rel="nofollow" target="_blank">Facebook</a>, <a href="https://twitter.com/lcfamerica" rel="nofollow" target="_blank">Twitter</a>, and <a href="https://www.instagram.com/lcfamerica/" rel="nofollow" target="_blank">Instagram</a>.

How a Small Cell Lung Cancer Patient  is Outliving the Odds

Living with lung cancer isn't a solitary activity. It's a daily action in concert with the support of family, friends, loved ones, and even people who seem to appear out of the blue to offer support. In this Valentine's Day episode, we explore the wonderful ways people living with lung cancer have found support and what it means to them. Guests LCFA Speakers Bureau members Carol Brickell, Terri Conneran, Lisa Goldman, and Frank McKenna. Episode Show Notes   LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

Living with lung cancer isn't a solitary activity. It's a daily action in concert with the support of family, friends, loved ones, and even people who seem to appear out of the blue to offer support. In this Valentine's Day episode, we explore the wonderful ways people living with lung cancer have found support and what it means to them. Guests LCFA Speakers Bureau members <a href="https://lcfamerica.org/lung-cancer-info/survivors/self-advocacy-revealed-lung-cancer/" rel="nofollow" target="_blank">Carol Brickell</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/diagnosis-asthma-or-lung-cancer/" rel="nofollow" target="_blank">Terri Conneran</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/persistent-cough-and-lung-cancer/" rel="nofollow" target="_blank">Lisa Goldman</a>, and <a href="https://lcfamerica.org/lung-cancer-info/survivors/cough-and-lung-cancer/" rel="nofollow" target="_blank">Frank McKenna</a>. <a href="https://lcfamerica.org/wp-content/uploads/2021/02/HWA-Ep-15-Show-Notes.pdf" rel="nofollow" target="_blank">Episode Show Notes</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org/" rel="nofollow" target="_blank">lcfamerica.org</a>.

V-Day Special: # Lung Cancer Love Stories

LCFA's driving mission is to fund lung cancer research grants, the critical early-stage research that paves the way to much bigger funding for treatment breakthroughs and clinical trials. Our Young Investigators grant fund this cutting-edge research that is leading to some of the most exciting, innovative lung cancer research that will ultimately lead to saving lives and helping people living with lung cancer live longer, healthier lives. Listen in to a fascinating behind-the-scenes conversation with LCFA's founders and the head of its scientific advisory board about the importance of this funding in the fight against lung cancer. Guests Dr. David Carbone, The Ohio State University Marta Kauffman, LCFA Board Member Dr. Triparna Sen, LCFA Young Investigator Dr. Jarushka Naidoo, LCFA Young Investigator Dr. Alice Berger, LCFA Young Investigator Dr. Christine Lovly, LCFA Young Investigator   Show Notes for this episode   LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

LCFA's driving mission is to fund lung cancer research grants, the critical early-stage research that paves the way to much bigger funding for treatment breakthroughs and clinical trials. Our Young Investigators grant fund this cutting-edge research that is leading to some of the most exciting, innovative lung cancer research that will ultimately lead to saving lives and helping people living with lung cancer live longer, healthier lives. Listen in to a fascinating behind-the-scenes conversation with LCFA's founders and the head of its scientific advisory board about the importance of this funding in the fight against lung cancer. Guests <a href="https://lcfamerica.org/about/advisory/board/dr-david-carbone-m-d-ph-d/" rel="nofollow" target="_blank">Dr. David Carbone, The Ohio State University</a> <a href="https://lcfamerica.org/about/board/director/marta-kauffman/" rel="nofollow" target="_blank">Marta Kauffman, LCFA Board Member</a> <a href="https://lcfamerica.org/research-grants/improving-small-cell-lung-cancer-life-expectancy/" rel="nofollow" target="_blank">Dr. Triparna Sen, LCFA Young Investigator</a> <a href="https://lcfamerica.org/research-grants/precision-medicine-and-lung-cancer/" rel="nofollow" target="_blank">Dr. Jarushka Naidoo, LCFA Young Investigator</a> <a href="https://lcfamerica.org/research-grants/leading-cause-of-death-in-women/" rel="nofollow" target="_blank">Dr. Alice Berger, LCFA Young Investigator</a> <a href="https://lcfamerica.org/research-grants/grants/awarded/christine-lovly/" rel="nofollow" target="_blank">Dr. Christine Lovly, LCFA Young Investigator</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/02/HWA-Ep-14-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes for this episode</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

Inside LCFA’s Mission to Fund Lung Cancer Research Grants: Research is the Key to Saving Lives

Science developed COVID vaccines in record time, but now that they’re ready, will people take them? Distrust among communities of color, especially historically disadvantaged African American communities, and a lack of data on the vaccine among people living with lung cancer are proving challenging to the vaccine rollout. In this episode, we talk to an African American pulmonary surgeon who volunteered for a phase 3 coronavirus clinical trial, and African American lung cancer patient advocates about their vaccine concerns and what questions they’ll be asking their own doctors about taking a vaccine. Guests Dr. David Tom Cooke, UC Davis Health Montessa Lee, living with Small Cell Lung Cancer, LCFA Speaker Bureau Laronica Conway, #LCSM Co-Founder, LCFA Speaker Bureau   Show Notes

Science developed COVID vaccines in record time, but now that they’re ready, will people take them? Distrust among communities of color, especially historically disadvantaged African American communities, and a lack of data on the vaccine among people living with lung cancer are proving challenging to the vaccine rollout. In this episode, we talk to an African American pulmonary surgeon who volunteered for a phase 3 coronavirus clinical trial, and African American lung cancer patient advocates about their vaccine concerns and what questions they’ll be asking their own doctors about taking a vaccine. Guests <a href="https://health.ucdavis.edu/team/surgicalservices/1144/david-cooke---cancer---surgery---cardiothoracic---surgery---thoracic---surgery---robotic---robotic-surgery-sacramento" rel="nofollow" target="_blank">Dr. David Tom Cooke, UC Davis Health</a> <a href="https://lcfamerica.org/lung-cancer-info/survivors/small-cell-lung-cancer/" rel="nofollow" target="_blank">Montessa Lee</a>, living with Small Cell Lung Cancer, LCFA Speaker Bureau <a href="https://lcfamerica.org/lung-cancer-info/heroes/mothers-day-gift/" rel="nofollow" target="_blank">Laronica Conway</a>, #LCSM Co-Founder, LCFA Speaker Bureau <a href="https://lcfamerica.org/wp-content/uploads/2021/01/Episode-13-Show-Notes-.pdf" rel="nofollow" target="_blank">Show Notes</a>

Is the COVID vaccine safe? Building trust in coronavirus vaccines

What gets you out of bed in the morning? For people living with lung cancer, it's family, friends, work, community involvement, favorite activities and so much more. We'll find out what living with lung cancer looks like from patient advocates who are living longer, healthier lives thanks to advances in lung cancer research. Guests  LCFA Speakers Bureau Members: - Frank McKenna, Terri Conneran, Jill Feldman, Gina Hollenbeck, Lysa Buonanno, April Rempfer, Lisa Goldman David Sturges, LCFA Founder and Treasurer Kim Norris, LCFA Co-founder and President   Show Notes for this episode   LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

What gets you out of bed in the morning? For people living with lung cancer, it's family, friends, work, community involvement, favorite activities and so much more. We'll find out what living with lung cancer looks like from patient advocates who are living longer, healthier lives thanks to advances in lung cancer research. Guests LCFA Speakers Bureau Members: - <a href="https://lcfamerica.org/lung-cancer-info/survivors/cough-and-lung-cancer/" rel="nofollow" target="_blank">Frank McKenna</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/diagnosis-asthma-or-lung-cancer/" rel="nofollow" target="_blank">Terri Conneran</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/ovecoming-history-lung-cancer/" rel="nofollow" target="_blank">Jill Feldman</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/alk-positive-lung-cancer/" rel="nofollow" target="_blank">Gina Hollenbeck</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/lung-cancer-cat-scan/" rel="nofollow" target="_blank">Lysa Buonanno</a>, <a href="https://lcfamerica.org/lung-cancer-info/heroes/fathers-day-tribute/" rel="nofollow" target="_blank">April Rempfer</a>, <a href="https://lcfamerica.org/lung-cancer-info/survivors/persistent-cough-and-lung-cancer/" rel="nofollow" target="_blank">Lisa Goldman</a> <a href="https://lcfamerica.org/survivor/david-sturges/" rel="nofollow" target="_blank">David Sturges, LCFA Founder and Treasurer</a> <a href="https://lcfamerica.org/about/board/director/kim-norris/" rel="nofollow" target="_blank">Kim Norris, LCFA Co-founder and President</a> <a href="https://lcfamerica.org/wp-content/uploads/2021/01/Episode-12-Show-Notes.pdf" rel="nofollow" target="_blank">Show Notes for this episode</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

How These Patient Advocates Show the Importance of Lung Cancer Research

How do you spend time with family during the holidays while staying safe from Covid-19? Signs of Covid fatigue (like not wearing masks and gathering in larger groups) are leading to another spike in positivity rates just as flu season ramps up. We'll talk to a psychologist at the University of Colorado Medical Center about how to maintain the resolve to stay safe and healthy, and hear from a University of Minnesota Medical School pulmonologist about the latest research and advice on avoiding Covid-19. Guests Dr. Laura Melton, Clinical Health Psychologist at UC Health Dr. David Ingbar, Pulmonologist at University of Minnesota Medical School Episode 11 Show Notes LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

How do you spend time with family during the holidays while staying safe from Covid-19? Signs of Covid fatigue (like not wearing masks and gathering in larger groups) are leading to another spike in positivity rates just as flu season ramps up. We'll talk to a psychologist at the University of Colorado Medical Center about how to maintain the resolve to stay safe and healthy, and hear from a University of Minnesota Medical School pulmonologist about the latest research and advice on avoiding Covid-19. Guests <a href="https://www.cudoctors.com/Find_A_Doctor/Profile/22857" rel="nofollow" target="_blank">Dr. Laura Melton</a>, Clinical Health Psychologist at UC Health <a href="https://med.umn.edu/bio/pulmonary-allergy-critical-car/david-ingbar" rel="nofollow" target="_blank">Dr. David Ingbar</a>, Pulmonologist at University of Minnesota Medical School <a href="https://lcfamerica.org/wp-content/uploads/2020/12/Episode-11-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 11 Show Notes</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

11 - Top Tips for Battling COVID Fatigue This Holiday Season

This podcast is so helpful- lots of great information about living with lung cancer, new treatments, the research that&#39;s happening. It really gives a lot of reasons to be hopeful!

Incredibly helpful information about lung cancer

Hope With Answers: Living With Lung Cancer

If you've never heard of a thoracic oncologist, biomarker testing, or don't know what information you're looking for a second opinion, you aren't alone! A lung cancer diagnosis can send you reeling into a confusing world where you feel like you don't speak the language. In this 3-episode series called the 1st Seven Days, the Hope With Answers: Living With Lung Cancer podcast team helps you manage those initial days of a lung cancer diagnosis with a roadmap that helps you find the right doctor, get the right testing, and start to create the right treatment plan. In part 2 of this series, you'll get medical advice from lung cancer expert Dr. David Carbone of The Ohio State University about biomarker testing and how to get a second opinion. Also, get a crash course in the lingo that you'll need to manage your lung cancer diagnosis from people currently living with lung cancer. Guests Dr. David Carbone, Oncologist at The Ohio State University Resources Episode 07.2 Show Notes Get Help with Your First 7 Steps LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

If you've never heard of a thoracic oncologist, biomarker testing, or don't know what information you're looking for a second opinion, you aren't alone! A lung cancer diagnosis can send you reeling into a confusing world where you feel like you don't speak the language. In this 3-episode series called the 1st Seven Days, the Hope With Answers: Living With Lung Cancer podcast team helps you manage those initial days of a lung cancer diagnosis with a roadmap that helps you find the right doctor, get the right testing, and start to create the right treatment plan. In part 2 of this series, you'll get medical advice from lung cancer expert Dr. David Carbone of The Ohio State University about biomarker testing and how to get a second opinion. Also, get a crash course in the lingo that you'll need to manage your lung cancer diagnosis from people currently living with lung cancer. Guests <a href="https://lcfamerica.org/about/advisory/board/dr-david-carbone-m-d-ph-d/" rel="nofollow" target="_blank">Dr. David Carbone, Oncologist at The Ohio State University</a> Resources <a href="https://lcfamerica.org/wp-content/uploads/2020/05/Episode-07.2-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 07.2 Show Notes</a> <a href="https://lcfamerica.org/lung-cancer-info/hope-with-answers-podcast/first-7-steps/" rel="nofollow" target="_blank">Get Help with Your First 7 Steps</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

07.2 - The First 7 Days: Do you speak cancer? Learning a new lung cancer vocabulary

"I have lung cancer, now what?" The days following a lung cancer diagnosis are often a blur of confusion, fear, doctor's appointments, and tough conversations with family and friends. First and foremost, it feels like treatment needs to start happening NOW, but rest assured, you have time to set up a treatment plan that works for you. In this 3-episode series called the 1st Seven Days, the Hope With Answers: Living With Lung Cancer podcast team helps you manage those initial days of a lung cancer diagnosis with a roadmap that helps you find the right doctor, get the right testing, and start to create the right treatment plan. In part 1 of this series, you'll hear reassuring medical advice from lung cancer expert Dr. David Carbone of The Ohio State University, and find out what a group of people living with lung cancer wish they had known about lung cancer in those first seven days: you have time to get the right diagnosis, the right treatment plan, and the right team. Guests Dr. David Carbone, Oncologist at The Ohio State University Resources Episode 07.1 Show Notes Get Help with Your First 7 Steps LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

"I have lung cancer, now what?" The days following a lung cancer diagnosis are often a blur of confusion, fear, doctor's appointments, and tough conversations with family and friends. First and foremost, it feels like treatment needs to start happening NOW, but rest assured, you have time to set up a treatment plan that works for you. In this 3-episode series called the 1st Seven Days, the Hope With Answers: Living With Lung Cancer podcast team helps you manage those initial days of a lung cancer diagnosis with a roadmap that helps you find the right doctor, get the right testing, and start to create the right treatment plan. In part 1 of this series, you'll hear reassuring medical advice from lung cancer expert Dr. David Carbone of The Ohio State University, and find out what a group of people living with lung cancer wish they had known about lung cancer in those first seven days: you have time to get the right diagnosis, the right treatment plan, and the right team. Guests <a href="https://lcfamerica.org/about/advisory/board/dr-david-carbone-m-d-ph-d/" rel="nofollow" target="_blank">Dr. David Carbone, Oncologist at The Ohio State University</a> Resources <a href="https://lcfamerica.org/wp-content/uploads/2020/05/Episode-07.1-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 07.1 Show Notes</a> <a href="https://lcfamerica.org/lung-cancer-info/hope-with-answers-podcast/first-7-steps/" rel="nofollow" target="_blank">Get Help with Your First 7 Steps</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

07.1 - The First 7 Days: How to get the right diagnosis, the right treatment plan, and the right team

Cancer clinical trials can be a lung cancer patient's best option for accessing the most promising new treatments. It's important to understand how clinical trials work and how to talk to your doctor about which trial might be a good fit. In this episode of the Hope With Answers: Living With Lung Cancer podcast, we talk to a veteran of four lung cancer clinical trials (and the trials of online dating!) Linnea Olson, lung cancer advocates and great friends Jill Feldman, Ivy Elkins, and Lysa Buonanno about how they incorporate advocacy into their busy lives. Plus, get more detail on what to expect in a clinical trial from advocate Janet Freeman-Daily and lung cancer expert Dr. Ross Camidge of the University of Colorado Hospital. Guests  Linnea Olson, Lung cancer patient and advocate Lung cancer advocates Jill Feldman, Ivy Elkins, &amp; Lysa Buonanno Dr. Ross Camidge, of the University of Colorado Hospital and lung cancer advocate Janet Freeman-Daily Resources: Information on clinical trials Hope With Answers videos about clinical trials  Episode 06 Show Notes LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

Cancer clinical trials can be a lung cancer patient's best option for accessing the most promising new treatments. It's important to understand how clinical trials work and how to talk to your doctor about which trial might be a good fit. In this episode of the Hope With Answers: Living With Lung Cancer podcast, we talk to a veteran of four lung cancer clinical trials (and the trials of online dating!) Linnea Olson, lung cancer advocates and great friends Jill Feldman, Ivy Elkins, and Lysa Buonanno about how they incorporate advocacy into their busy lives. Plus, get more detail on what to expect in a clinical trial from advocate Janet Freeman-Daily and lung cancer expert Dr. Ross Camidge of the University of Colorado Hospital. Guests <a href="https://lcfamerica.org/survivor/linnea-olson/" rel="nofollow" target="_blank">Linnea Olson</a>, Lung cancer patient and advocate Lung cancer advocates <a href="https://lcfamerica.org/lung-cancer-info/survivors/ovecoming-history-lung-cancer/" rel="nofollow" target="_blank">Jill Feldman</a>, <a href="https://lcfamerica.org/survivor/ivy-elkins/" rel="nofollow" target="_blank">Ivy Elkins</a>, &amp; <a href="https://lcfamerica.org/survivor/lysa-buonanno/" rel="nofollow" target="_blank">Lysa Buonanno</a> <a href="https://www.cudoctors.com/Find_A_Doctor/Profile/18871" rel="nofollow" target="_blank">Dr. Ross Camidge</a>, of the University of Colorado Hospital and lung cancer advocate <a href="https://lcfamerica.org/survivor/janet-freeman-daily/" rel="nofollow" target="_blank">Janet Freeman-Daily</a> Resources: <ul><li><a href="https://lcfamerica.org/research-grants/learn-about-clinical-trials/" rel="nofollow" target="_blank">Information on clinical trials</a></li> <li><a href="https://lcfamerica.org/lung-cancer-info/hope-with-answers/clinical-trials-videos/" rel="nofollow" target="_blank">Hope With Answers videos about clinical trials</a></li> </ul> <a href="https://lcfamerica.org/wp-content/uploads/2020/05/Episode-06-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 06 Show Notes</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

06 - What Should I Know About Lung Cancer Clinical Trials?

Early detection of lung cancer can mean that lung cancer patients have more treatment options and a far greater chance of survival. The 5-year survival rate for those diagnosed before the cancer has spread rises from 18 out of every 100 people to 55 out of every 100. But, the key is being tested for lung cancer early. Many times, there are no early signs of lung cancer in its early stages. Instead, most lung cancers are diagnosed in the late stages of the disease, making treatment more problematic, and as a result, significantly reducing the overall lung cancer survival rate. Today on the Hope With Answers: Living With Lung Cancer podcast, we talk to 2-time lung cancer patient and LCFA co-founder David Sturges about how early detection of lung cancer helped save his life. We'll also hear from lung cancer specialist Dr. Denise Aberle about the importance of early diagnosis. Finally, we'll get an idea of a new type of treatment that may make lung cancer surgery easier to perform and prevent a recurrence.GuestsDavid Sturges, Lung cancer patient and LCFA Co-founder Dr. Denise Aberle, Thoracic Radiologist at UCLA Medical Center Kellie Smith, Ph.D., LCFA Young Investigator and Johns Hopkins Assistant Professor of Oncology   Episode 05 Show Notes LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

Early detection of lung cancer can mean that lung cancer patients have more treatment options and a far greater chance of survival. The 5-year survival rate for those diagnosed before the cancer has spread rises from 18 out of every 100 people to 55 out of every 100. But, the key is being tested for lung cancer early. Many times, there are no early signs of lung cancer in its early stages. Instead, most lung cancers are diagnosed in the late stages of the disease, making treatment more problematic, and as a result, significantly reducing the overall lung cancer survival rate. Today on the Hope With Answers: Living With Lung Cancer podcast, we talk to 2-time lung cancer patient and LCFA co-founder David Sturges about how early detection of lung cancer helped save his life. We'll also hear from lung cancer specialist Dr. Denise Aberle about the importance of early diagnosis. Finally, we'll get an idea of a new type of treatment that may make lung cancer surgery easier to perform and prevent a recurrence.Guests <a href="https://lcfamerica.org/survivor/david-sturges/" rel="nofollow" target="_blank">David Sturges</a>, Lung cancer patient and LCFA Co-founder <a href="https://www.uclahealth.org/denise-aberle" rel="nofollow" target="_blank">Dr. Denise Aberle</a>, Thoracic Radiologist at UCLA Medical Center <a href="https://lcfamerica.org/research-grants/grants/awarded/dr-kellie-smith-2/" rel="nofollow" target="_blank">Kellie Smith, Ph.D.</a>, LCFA Young Investigator and Johns Hopkins Assistant Professor of Oncology <a href="https://lcfamerica.org/wp-content/uploads/2020/04/Episode-05-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 05 Show Notes</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org/" rel="nofollow" target="_blank">lcfamerica.org</a>.

05 - Give Yourself a Fighting Chance: Early Detection of Lung Cancer

What does it feel like living with lung cancer day-to-day? Lung cancer patient and nurse Gina Hollenbeck weighs in. Plus, we drop in on Jill Feldman and Steven Petrow's discussion about an oft-dreaded conversation: how to tell the family you have cancer. Then, hear from Kim Norris about the recent good news about the impact of lung cancer and what she has witnessed in the development of lung cancer treatments over the past 10 years. Guests  Gina Hollenbeck, Nurse and lung cancer patient  Jill Feldman, Lung cancer patient/advocate Steven Petrow, Manners and civility expert and journalist Kim Norris, LCFA Co-founder and President Episode 04 Show Notes Resources  Death Rate Drop: Lung Cancer Research Key   LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

What does it feel like living with lung cancer day-to-day? Lung cancer patient and nurse Gina Hollenbeck weighs in. Plus, we drop in on Jill Feldman and Steven Petrow's discussion about an oft-dreaded conversation: how to tell the family you have cancer. Then, hear from Kim Norris about <a href="https://lcfamerica.org/research-grants/latest/research/death-rate-drop-lung-cancer-research-key/" rel="nofollow" target="_blank">the recent good news about the impact of lung </a><a href="https://lcfamerica.org/research-grants/latest/research/death-rate-drop-lung-cancer-research-key/" rel="nofollow" target="_blank">cancer</a> and what she has witnessed in the development of lung cancer treatments over the past 10 years. Guests <a href="https://lcfamerica.org/lung-cancer-info/survivors/alk-positive-lung-cancer/" rel="nofollow" target="_blank">Gina Hollenbeck, Nurse and lung cancer patient </a> <a href="https://lcfamerica.org/lung-cancer-info/survivors/ovecoming-history-lung-cancer/" rel="nofollow" target="_blank">Jill Feldman, Lung cancer patient/advocate</a> <a href="https://stevenpetrow.com/" rel="nofollow" target="_blank">Steven Petrow, Manners and civility expert and journalist</a> <a href="https://lcfamerica.org/about/board/director/kim-norris/" rel="nofollow" target="_blank">Kim Norris, LCFA Co-founder and President</a> <a href="https://lcfamerica.org/wp-content/uploads/2020/03/Episode-04-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 04 Show Notes</a> Resources  <a href="https://lcfamerica.org/research-grants/latest/research/death-rate-drop-lung-cancer-research-key/" rel="nofollow" target="_blank">Death Rate Drop: Lung Cancer Research Key</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

04 - The Lung Cancer Conversation: How to tell family you have cancer

The Covid-19 pandemic has serious implications for everyone, but it's especially concerning for lung cancer patients. In this special episode recorded on 03/16/2020, we hear how some lung cancer patients are keeping up their spirits. Learn how they are filling the refrigerator while staying safe at home. Get the latest information on how Covid-19 can affect lung cancer patients from Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Hospital. GuestsLCFA Speakers Bureau Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Hospital Kim Norris, Lung Cancer Foundation of America Co-founder and President Episode 03.6 Show Notes

The Covid-19 pandemic has serious implications for everyone, but it's especially concerning for lung cancer patients. In this special episode recorded on 03/16/2020, we hear how some lung cancer patients are keeping up their spirits. Learn how they are filling the refrigerator while staying safe at home. Get the latest information on how Covid-19 can affect lung cancer patients from Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Hospital. Guests <a href="https://lcfamerica.org/about/lung-cancer-community-outreach/" rel="nofollow" target="_blank">LCFA Speakers Bureau</a> <a href="https://medschool.cuanschutz.edu/colorado-cancer-center" rel="nofollow" target="_blank">Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Hospital</a> <a href="https://lcfamerica.org/about/" rel="nofollow" target="_blank">Kim Norris, Lung Cancer Foundation of America Co-founder and President</a> <a href="https://lcfamerica.org/wp-content/uploads/2020/03/Episode-03-6-Special-News-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 03.6 Show Notes</a>

03.6 - [SPECIAL NEWS] Coronavirus and lung cancer: Hear what lung cancer patients have to say

The global coronavirus (COVID-19) pandemic has serious implications for us all, but it's especially concerning for the immunocompromised. In this episode, we discuss what you need to know about coronavirus and lung cancer. We'll talk with lung cancer patients about how difficult it is to get a coronavirus test and the challenges families and caregivers have living with someone with lung cancer during COVID-19. Plus, hear from lung cancer specialist at Cedars-Sinai Cancer Center, Dr. Karen Reckamp, to understand how COVID-19 specifically affects lung cancer patients, and how can all do our part to protect our communities. Guests Janet Freeman-Daily, lung cancer patient and advocate  Lisa Goldman, lung cancer patient and advocate Karen Reckamp, MD, MS Director, Division of Medical Oncology Associate Director, Clinical Research Cedars-Sinai Cancer  Kim Norris, LCFA Co-founder and President    Resources 03.5 Show Notes  Covid-19 information on LCFAmerica.org   LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org.

The global coronavirus (COVID-19) pandemic has serious implications for us all, but it's especially concerning for the immunocompromised. In this episode, we discuss what you need to know about coronavirus and lung cancer. We'll talk with lung cancer patients about how difficult it is to get a coronavirus test and the challenges families and caregivers have living with someone with lung cancer during COVID-19. Plus, hear from lung cancer specialist at Cedars-Sinai Cancer Center, Dr. Karen Reckamp, to understand how COVID-19 specifically affects lung cancer patients, and how can all do our part to protect our communities. Guests <a href="https://lcfamerica.org/survivor/janet-freeman-daily/" rel="nofollow" target="_blank">Janet Freeman-Daily, lung cancer patient and advocate </a> <a href="https://lcfamerica.org/lung-cancer-info/survivors/persistent-cough-and-lung-cancer/" rel="nofollow" target="_blank">Lisa Goldman, lung cancer patient and advocate</a> <a href="https://www.cedars-sinai.org/newsroom/lung-cancer-expert-to-head-medical-oncology-at-cedars-sinai/" rel="nofollow" target="_blank">Karen Reckamp, MD, MS Director, Division of Medical Oncology Associate Director, Clinical Research Cedars-Sinai Cancer </a> <a href="https://lcfamerica.org/about/board/director/kim-norris/" rel="nofollow" target="_blank">Kim Norris, LCFA Co-founder and President </a> Resources 03.5 Show Notes  <a href="https://lcfamerica.org/research-grants/latest/research/coronavirus-and-lung-cancer-joint-statement-from-lung-cancer-advocacy-groups/" rel="nofollow" target="_blank">Covid-19 information on LCFAmerica.org</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>.

03.5 - [SPECIAL NEWS] Coronavirus and lung cancer: What you need to know

Lung cancer brings with it an incredible set of challenges, including one that’s almost unique to lung cancer patients: THE STIGMA. Patients with lung cancer who never smoked are asked immediately about their smoking history by doctors, friends, even complete strangers. Jill Feldman has fought against the lung cancer stigma for years – she teams up with manners and civility expert, Steven Petrow, to talk about ways to handle the things people say when you tell them you have lung cancer. Plus, lung cancer researcher Dr. Alice Berger sheds new light on lung cancer in women, particularly young non-smokers. Guests Jill Feldman, Lung cancer patient/advocate  Steven Petrow, Manners and civility expert and journalist Dr. Alice Berger, Researcher at Fred Hutchinson Cancer Research Center  LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org. Episode 03 Show Notes

Lung cancer brings with it an incredible set of challenges, including one that’s almost unique to lung cancer patients: THE STIGMA. Patients with lung cancer who never smoked are asked immediately about their smoking history by doctors, friends, even complete strangers. Jill Feldman has fought against the lung cancer stigma for years – she teams up with manners and civility expert, Steven Petrow, to talk about ways to handle the things people say when you tell them you have lung cancer. Plus, lung cancer researcher Dr. Alice Berger sheds new light on lung cancer in women, particularly young non-smokers. Guests <a href="https://lcfamerica.org/lung-cancer-info/survivors/ovecoming-history-lung-cancer/" rel="nofollow" target="_blank">Jill Feldman, Lung cancer patient/advocate </a> <a href="https://stevenpetrow.com/" rel="nofollow" target="_blank">Steven Petrow, Manners and civility expert and journalist</a> <a href="https://lcfamerica.org/research-grants/grants/awarded/dr-alice-berger/" rel="nofollow" target="_blank">Dr. Alice Berger, Researcher at Fred Hutchinson Cancer Research Center </a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="http://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>. <a href="https://lcfamerica.org/wp-content/uploads/2020/03/Episode-03-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 03 Show Notes</a>

03 - Lung Cancer Stigma: The things people say

Shelly Engfer-Triebenbach doesn’t sit still; she’s a very busy mom and music teacher – and now, an advocate for people living with lung cancer. Diagnosed with ALK lung cancer in 2013, we’ll talk to her about what it means to live with lung cancer day-to-day. We’ll also talk to researcher Dr. Alice Berger about her research and check in with LCFA Scientific Advisory Board member, Dr. Michael Weitz, about why research funding is so important. Guests Shelly Engfer-Triebenbach, Lung Cancer Patient/Advocate Dr. Alice Berger, Researcher at Fred Hutchinson Cancer Research Center Dr. Michael Weitz, LCFA Scientific Advisory Board Member  Episode 02 Show Notes LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org

Shelly Engfer-Triebenbach doesn’t sit still; she’s a very busy mom and music teacher – and now, an advocate for people living with lung cancer. Diagnosed with ALK lung cancer in 2013, we’ll talk to her about what it means to live with lung cancer day-to-day. We’ll also talk to researcher Dr. Alice Berger about her research and check in with LCFA Scientific Advisory Board member, Dr. Michael Weitz, about why research funding is so important. Guests <a href="https://lcfamerica.org/lung-cancer-info/survivors/value-of-a-second-opinion/" rel="nofollow" target="_blank">Shelly Engfer-Triebenbach, Lung Cancer Patient/Advocate</a> <a href="https://lcfamerica.org/research-grants/grants/awarded/dr-alice-berger/" rel="nofollow" target="_blank">Dr. Alice Berger, Researcher at Fred Hutchinson Cancer Research Center</a> <a href="https://lcfamerica.org/about/advisory/board/dr-michael-weitz-m-d/" rel="nofollow" target="_blank">Dr. Michael Weitz, LCFA Scientific Advisory Board Member </a> <a href="https://lcfamerica.org/wp-content/uploads/2020/03/Episode-02-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 02 Show Notes</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org/" rel="nofollow" target="_blank">lcfamerica.org</a>

02 - What does it mean to be “living with lung cancer”?

Lysa Buonanno talks about her lung cancer diagnosis and tumor marker tests pinpointed a specific biomarker that changed everything for her. Then, we'll discuss why Dr. David Carbone isn't offended by 2nd opinions, and hear from Kim Norris about her work to help people access the best possible treatments. Guests  Lysa Buonanno, Lung Cancer Patient/Advocate Dr. David Carbone, Thoracic Oncologist at The Ohio State University Kim Norris, LCFA Co-founder LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit lcfamerica.org. Episode 1: Show Notes

Lysa Buonanno talks about her lung cancer diagnosis and tumor marker tests pinpointed a specific biomarker that changed everything for her. Then, we'll discuss why Dr. David Carbone isn't offended by 2nd opinions, and hear from Kim Norris about her work to help people access the best possible treatments. Guests <a href="http://prez.ly/YKs" rel="nofollow" target="_blank">Lysa Buonanno, Lung Cancer Patient/Advocate</a> <a href="https://lcfamerica.org/about/advisory/board/dr-david-carbone-m-d-ph-d/" rel="nofollow" target="_blank">Dr. David Carbone, Thoracic Oncologist at The Ohio State University</a> <a href="https://lcfamerica.org/about/board/director/kim-norris/" rel="nofollow" target="_blank">Kim Norris, LCFA Co-founder</a> LCFA is a nonprofit dedicated to improving the survivorship of lung cancer patients by funding lung cancer research. Visit <a href="https://lcfamerica.org" rel="nofollow" target="_blank">lcfamerica.org</a>. <a href="https://lcfamerica.org/wp-content/uploads/2020/03/Episode-01-Show-Notes.pdf" rel="nofollow" target="_blank">Episode 1: Show Notes</a>

01 - I have lung cancer- what now?

The Best Multi-Part Documentaries, with documentaries on Obama, Federer vs Nadal, the making of Star Wars, Netflix vs Blockbuster and more. Add episodes you're interested into your queue below!

Best Multi-Part Documentaries

The best podcast episodes of anyone with an interesting story. With famous guests like Obama, LeBron James, Drake, Oprah Winfrey, Richard Branson, Michelle Obama, Serena Williams, to anyone who has a unique and interesting story to tell. Add episodes you're interested into your queue below!